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 Abstract 
A series of experiments were carried out to assess the effects and interactions of 
isomerisable lipid analogues, small molecules, and enzyme catalysed substrates 
on the structure and dynamics of lipid bilayers. 
 
Modulation of Enzyme Activity Using an Azobenzene-Containing Lipid Analogue 
– An azobenzene-containing phosphocholine lipid analogue (bis-Azo-PC) was 
synthesised and incorporated into 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC) liposomes containing diacylglycerol kinase (DGK) in order to assess the 
effect of photoisomerisation of the azobenzene group on the activity of the 
protein.  The increase in volume of bis-Azo-PC in the cis state should have a 
significant effect on protein activity as bilayer tension increases.  Protein activity 
was measured using an enzyme activity assay.  The difference in specific activity 
between the trans and cis states of the azobenzene was too small to discern a 
significant effect on protein activity. 
 
Lipid Phase Behaviour – The phase behaviour of 1,2-dipalmitoyl-sn-glycerol-3-
phosphocholine-d62 (d62-DPPC) samples containing cholesterol and the serotonin 
receptor agonist drugs quipazine and LY-165,135 was analysed using proton and 
deuterium NMR spectroscopy and differential scanning calorimetry (DSC).  The 
effect of quipazine and LY-165,135 on d62-DPPC was an elongation of the gel-
to-fluid lamellar phase transition, lowering of the start of the phase transition, 
and disappearance of the ripple phase observed in d62-DPPC alone.  The effect of 
cholesterol on d62-DPPC was a smoothing of the phase transition due to the 
presence of the liquid-ordered phase.  Spectra of d62-DPPC, cholesterol and 
quipazine also show the presence of the liquid-ordered phase.  Spectra of d62-
DPPC and cholesterol with LY-165,135 show that the drug widens the 
temperature range over which the liquid-ordered phase exists.  These results 
indicate that the presence of small molecules such as serotonin-receptor agonists 
can have a significant effect on the phase behaviour of the lipid bilayer. 
 
Analysis of Drug Localisation and Orientation in a Model Membrane by NMR 
Spectroscopic Methods – NOESY cross-relaxation rates were used to generate 
location probabilities for serotonin-receptor agonist drugs in d62-DPPC bilayers 
 with and without cholesterol.  Both drugs were found to locate in the interface 
region of the bilayer, although they had difference orientations relative to the 
bilayer normal; quipazine was oriented parallel to the d62-DPPC molecules, while 
LY-165,135 was oriented perpendicular to the lipid.  The presence of cholesterol 
was found to affect the drugs‟ positions in the bilayer.  Quipazine was pushed 
further towards the centre of the bilayer (the acyl chain termini) when the sample 
was in the fluid lamellar phase.  The effect on LY-165,135, conversely, was to 
push it to towards the headgroup region as the fluid lamellar phase approached.  
The drug interactions with cholesterol during the mixed [lo + ld] phases indicate 
that these compounds may be partitioning into the liquid-ordered phase under 
these conditions. 
 
Use of an Enzyme Substrate to Investigate Bilayer Dynamics – DROSS NMR, 
31
P NMR and fluorescence emission spectroscopy were used to analyse the effect 
of catalysing an enzyme substrate on a lipid bilayer.  1,2-Dioctanoyl-sn-glycerol 
(DOG) is a substrate of DGK.  DGK phosphorylates DGK in the presence of 
adenosine triphosphate (ATP), producing phosphatidic acid (PA).  DROSS was 
used to generate order parameters while fluorescence emission spectroscopy was 
used to give an indication of bilayer tension.  Bilayer tension and order 
parameters were lower for the sample containing PA co-dissolved with DOPC 
relative to the sample containing catalysed PA.  This is due to sequestration of 
the catalysed PA in the immediate vicinity of the protein rather than an even 
distribution throughout the bilayer (as observed for co-dissolved PA), which 
affects the physical properties of the bilayer. 
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 Abbreviations 
 
5-HT   5-Hydroxytryptamine 
ADP   Adenosine diphosphate 
AFM   Atomic force microscopy 
APS   Ammonium persulphate 
ar.   Aromatic (I.R. characterisation) 
ATP   Adenosine triphosphate 
bR   Bacteriorhodopsin 
brs   Broad singlet (NMR characterisation) 
COSY   Correlation spectroscopy 
CP   Cross-polarisation 
CTM   Central terminal methyl 
DAG   Diacylglycerol 
DBG   Dibutyrylglycerol 
DBGP   Dibutyrylglycerol phosphate 
dd   Double doublet (NMR characterisation) 
ddd   Double double doublet (NMR characterisation) 
DEPT   Distortionless enhancement by polarisation transfer 
DGK   Diacylglycerol kinase 
DM   n-Decyl-β-D-maltopyranoside 
DOPC   1,2-Dioleoyl-sn-glycero-3-phosphocholine 
DPPC   1,2-Dipalmitoyl-sn-glycero-3-phosphocholine 
DRM   Detergent-resistant membrane 
DROSS Dipolar recoupling on-axis with scaling and shape 
preservation 
DSC   Differential scanning calorimetry 
EDTA   Ethylenediaminetetraacetic acid 
FID   Free induction decay 
FRET   Fluorescence energy resonance transfer 
FTIR   Fourier transform infrared spectroscopy 
GPCR   G-coupled protein receptor 
GPI   Glycophosphatidylinositol 
HSQC   Heteronuclear single-quantum coherence 
 IMP   Integral membrane protein 
IPTG   Isopropyl-β-D-thiogalactopyranoside 
Lα   Fluid lamellar phase 
Lβ   Gel phase 
ld   Liquid-disordered phase 
lo   Liquid-ordered phase 
LB   Luria-Burtani 
LDH   Lactate dehydrogenase 
LGCI   Ligand-gated ion channel 
LY   LY-165,135 
M1   First spectral moment (
2
H-NMR) 
M2   Second spectral moment (
2
H-NMR) 
m   Medium (I.R. characterisation) 
m   Multiplet (NMR characterisation) 
MAS   Magic-angle spinning 
m. p.   Melting point 
MscL   Mechanosensitive channel of large conductance 
NADH  Nicotinamide adenine dinucleotide 
NMR   Nuclear magnetic resonance  
NOE   Nuclear Overhauser effect 
NOESY  Nuclear Overhauser effect spectroscopy 
NTA   Nitrilotriacetic acid 
OG   n-Octyl-β-D-glucopyranoside 
Pβ’   Ripple phase 
PC   Phosphocholine 
PE   Phosphoethanolamine 
PEP   Phosphoenolpyruvate 
PG   Phosphoglycerol 
PI   Phosphoinositol 
PIPES   1,4-Piperazine-bis(ethanesulphonic acid) 
PK   Pyruvate kinase 
PMSF   Phenylmethanesulphonyl fluoride 
PS   Phosphoserine 
Q   Quipazine 
 RF   Radiofrequency 
Rf   Retention factor (TLC) 
s   Strong (I.R. characterisation) 
SCEE   Stored curvature elastic energy 
SDS   Sodium dodecyl sulphate 
SDS-PAGE  SDS-polyacrylamide gel electrophoresis 
str.   Stretch (I.R. characterisation) 
t   Triplet (NMR characterisation) 
TEMED  N,N,N’,N’-Tetramethylethylenediamine 
TLC   Thin layer chromatography 
TMS   Tetramethylsilane 
TPPM   Two pulse phase modulation 
TRIS   Tris(hydroxymethyl)aminomethane 
UV   Ultraviolet 
w   Weak (I.R. characterisation)   
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 Chapter 1: Introduction 
 
Part 1. The Cell Membrane 
 
Definition - Cell membranes are biological assemblies which compartmentalise 
all living cells.  They were once thought to be a passive bystander of the 
activities occurring in the cell‟s interior; however now it is known that the cell 
membrane itself is as dynamic an environment as the cytoplasm.   
 
As well as the various lipid dynamics and phase formations, there are also a 
variety of protein-mediated processes taking place.  The main role of cell 
membranes is to encapsulate and separate the cell from its external environment; 
additionally, membranes within the eukaryotic cytoplasm compartmentalise 
organelles.  The membrane is selectively permeable to a variety of molecules, 
mediated by the membrane proteins in the form of ion channels and gates.  
Membranes are host to a range of extremely important protein-mediated 
reactions; for example, the energy-conversion processes of photosynthesis and 
oxidative phosphorylation are both membrane-based.  Membrane proteins 
account for thirty to forty percent of a proteome and are also thought to account 
for up to seventy percent of drug targets
1-3
.   
 
 
 
 
 
The classic Singer-Nicholson model describes the cell membrane as a semi-
permeable “fluid mosaic” in which membrane proteins are surrounded by a 
membrane lipid matrix
4
 (Figure 1.1).  The lipid matrix is formed of two back-to-
Figure 1.1. The classic Singer-Nicholson model of the cell membrane, showing 
integral membrane proteins in a lipid matrix
4
 
 
 back lipid monolayers (six to ten nanometres in width), primarily phospholipid, 
with the hydrophilic headgroups facing out to the aqueous environments of the 
cytoplasm and the extracellular space, and the hydrophobic hydrocarbon chains 
facing into the centre of the bilayer
4, 5
.   
 
Composition - Cell membranes are heterogeneous, composed of thousands of 
different lipid species, membrane proteins, and other biological molecules such 
as carbohydrates
6
.  The lipid species include phospholipids, sterols, glycolipids 
and sphingolipids.  The lipid composition of cell membranes varies with species, 
with cell type within the same species, and in response to various external and 
internal stimuli.  The cell composition is also observed to vary with certain 
disease states; for example, increased amounts of cholesterol were observed in 
erythrocyte plasma membranes of patients with various types of liver disease
7
.  
Cell membranes also contain a large variety of proteins, including receptors, 
transporters and structural proteins. 
 
Part 2. Membrane Lipids 
 
Lipid Structure - The majority of the lipid content in most eukaryotic and 
prokaryotic cells are phospholipids.  The general structure of the amphiphilic 
phospholipid molecule can be divided into three regions: the headgroup, the 
glycerol, and the chain or tail regions (Figure 1.2). 
 
 
 
Figure 1.2.  Structure of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) 
demonstrating the three regions: the hydrocarbon chain, the glycerol, and the 
headgroup regions 
 
 The tail region usually contains two hydrocarbon chains, which vary between 
fourteen and twenty-four carbon atoms in length, the most common lengths being 
sixteen or eighteen carbon atoms
8, 9
.  There are also varying degrees of 
saturation, with saturated, mono-unsaturated, and poly-unsaturated chains.  These 
hydrocarbon chains are usually linked to the headgroup region by an interfacial 
glycerol group.  The headgroup also varies in chemical composition.  The most 
common headgroups include phosphocholine (PC), phosphoethanolamine (PE), 
phosphoserine (PS), and phosphoglycerol (PG) (Figure 1.3).   
 
 
 
Figure 1.3.  Structures of phosphocholine (PC), phosphoethanolamine (PE) and 
phosphoserine (PS) headgroups, where R is the glycerol and chain region as 
shown in the structure of phosphocholine 
 
The identity of the phospholipid is therefore determined by the composition of 
the headgroup (e.g. PC, PE, PS, phosphoinositol (PI), etc.) and the length and 
saturation of the hydrocarbon tail.  The headgroups in general are polar and 
charged, and the charge density varies with the identity of the headgroup; for 
example, the charge density of PS is greater than that of PC.  The length of the 
hydrocarbon chain and the degree of saturation also affects the tail region of the 
membrane. 
 
Sphingolipids are a type of phospholipid which contains an amide linkage 
between the hydrocarbon chain and the headgroup in place of the glycerol 
linkage.  The hydrocarbon chain is normally eighteen or twenty carbon atoms in 
 length, varying in saturation.  The identity of the sphingolipid depends on the 
chemical nature of the headgroup and also includes PC, PE and PS headgroups 
(Figure 1.4). 
 
 
 
Figure 1.4.  Structures of sphingomyelin and ceramide headgroups, where R 
represents the hydrocarbon chains as shown in the structure of sphingomyelin 
 
Other membrane lipids include sterols and glycolipids.  Cholesterol is the most 
common sterol in the eukaryotic cell membrane, with the exception of fungi, 
bacteria and plants.  All sterols have the general structure of three cyclohexane 
rings and one cyclopentane ring with additional side-chains (Figure 1.5). 
 
 
 
Figure 1.5.  The structure of cholesterol, the most abundant sterol in the cell 
membrane, showing the three cyclohexane rings joined to a cyclopentane ring 
 
Glycolipids are lipids (including phospholipids and sphingolipids) with a 
carbohydrate headgroup; they are concentrated in the exofacial leaflet of the cell 
membrane.   
 Lipid Behaviour - In aqueous environments amphiphilic lipid molecules may 
self-organise into a number of forms, depending on the structure and 
concentration of the lipids present.  These forms include the lamellar, micellular 
and inverse hexagonal phases (Figure 1.6). 
 
 
         a)        b)               c) 
 
Figure 1.6.  Diagram showing some of the possible lipid phases in an aqueous 
environment, depending on lipid structure and concentration.  The micellular 
phase formed by lyso-lipids is depicted in a), the lamellar bilayer adopted by 
cylindrical lipids such as PCs is shown in b), and the inverse hexagonal phase 
formed by cone-shaped lipids such as PEs is shown in c) 
 
The form adopted by lipids in an aqueous environment is highly dependent on 
their structure, as demonstrated in Figure 1.6.  Lysolipids, containing a single 
hydrocarbon chain, and short chain lipids tend to spontaneously form micelles 
due to their tapering cone shape.  Cylindrical lipids, in which the headgroup 
occupies approximately the same cross sectional area as the hydrocarbon chain, 
spontaneously form lamellar bilayers, as observed in the cell membrane.  
Examples of lamellar-forming lipids include phosphocholines.  Cone-shaped 
lipids, in which the headgroup occupies a smaller volume than the hydrocarbon 
chain, tend to form the inverse hexagonal phase.  Cone-shaped lipids include 
phosphoethanolamines
6, 10, 11
. 
 
  
a)           b)         c)         d)            e)  f) 
 
Figure 1.7a - f.  Diagram showing approximate lipid shapes.  The shape that 
lipids adopt in the bilayer depends on the nature of the headgroup and 
hydrocarbon chains.  Lipids such as lyso-lipids, with a large headgroup relative 
to the volume of the hydrocarbon chain, adopt a tapering cone shape (a) and 
tend to form micelles; short-chain lipids (b) adopt a stunted cylindrical shape;  
lipids with a cylindrical shape (c), such as PC lipids, tend to form lamellar 
bilayers; and lipids with a cone shape, such as PE lipids (d) and interdigitated 
lipids (e), tend to form the inverse hexagonal.  Lipids with smaller headgroups (f) 
take up smaller volumes of space 
 
The shapes of various lipids are also influenced by saturation. The presence of 
double bonds leads to kinks in hydrocarbon chains, increasing the volume that 
the hydrocarbon chain region occupies, as observed for cone-shaped lipids; lack 
of saturation enables closer lipid packing. 
 
In a eukaryotic cell membrane environment, the bulk of the phospholipids are 
phosphocholines, leading to the lamellar lipid bilayer form observed.  This is the 
only form viable for biological life, as it provides encapsulation and 
compartmentalisation.   
 
Lipids in the lamellar phase may adopt several sub-phases depending on several 
factors, including temperature.  At low temperatures lipids adopt the Lβ or gel 
phase, in which there is minimal lateral or transbilayer diffusion of individual 
lipid molecules, minimal rotation of the lipid about the long axis, and relatively 
close packing.  The phase displays a high order parameter (a measure of the 
rigidity of the lipid molecule at various sections along its length, giving an 
indication of the freedom of movement in a particular region of the bilayer).  As 
 temperature increases the lipids enter the Lα or liquid-disordered (ld) phase.  In 
this phase there are increased lateral and transbilayer diffusions, increased 
rotations about the long axis, and increased chain isomerisations together with 
looser packing of molecules and a corresponding decrease in order parameter.   
Other sub-phases include the Lβ‟ or ripple phase, and the liquid-ordered (lo) 
phase, which is of particular interest.  The lo phase is intermediate between the 
gel and ld phases in its properties, and has been shown to coexist with both the 
gel and ld phases in model membranes by techniques such as NMR spectroscopy 
and fluorescence microscopy
6, 12-14
.  In cell membranes it may coexist with the ld 
phase.  The formation of the lo phase is induced by the presence of intercalation 
of relatively bulky sterols or sphingomyelin with the phospholipid molecules, 
reducing the freedom of movement of the phospholipids and increasing the 
bilayer pressure in the region.  The lo phase has a relatively high order parameter 
in comparison with the ld phase, but with fast lipid dynamics (Figure 1.8)
6, 15
. 
 
 
 
Figure 1.8.  Simplified diagram showing lipid phases.  At the lowest temperature, 
lipids adopt the gel phase.  As temperature increases lipids adopt the 
intermediate liquid-ordered phase, finally followed by the liquid-disordered 
phase 
 
 
 
 Bilayer Properties - The lipid bilayer can be considered as three separate regions, 
following the division of the general phospholipid molecule: the headgroup, 
glycerol, and hydrocarbon chain regions.  The headgroup region is highly 
hydrated.  Interactions between individual headgroup moieties depend on their 
charges and sizes, and attractive interactions may arise due to hydrogen bonding.  
Headgroup moieties are relatively flexible and disordered
11
.  The glycerol region, 
which acts as an interface between the headgroup and the hydrocarbon chain, is 
less hydrated than the headgroup region, and is more rigid than either of the 
neighbouring regions
11
.  Interactions in this region are due to hydrogen bond 
formation from the carbonyl groups.  The degree of hydration is lowest in the 
hydrocarbon chain region due to the hydrophobic character of the acyl chains.  
Interactions between neighbouring chains or protein residues are due to van der 
Waals‟ forces.   
 
The degree of saturation present (one or more double bonds) affects the volume 
and the packing of lipid molecules in this region; fully saturated chains pack 
more closely together than unsaturated chains, giving rise to less free volume.   
The presence of double bonds leads to the existence of areas of lower pressure or 
free volume in the bilayer, as well as conferring an amount of rigidity on the acyl 
chain.  This region has a high degree of disorder relative to the glycerol region, 
due to the flexibility of the acyl chains
11
.   
 
The physical properties of the bilayer include lipid packing; lipid phase; surface 
tension; bilayer lateral pressure; curvature stress and the associated stored 
curvature elastic energy (SCEE); and individual lipid dynamics.  There is an 
amount of surface tension present in lipid bilayers, which is due to competition 
between the attractive force between surface molecules and their immediately 
neighbouring molecules, and between surface molecules and the bulk of the 
molecules below the surface
11
.  The attraction to the bulk is stronger than the 
attraction to the neighbouring surface molecules, so the molecule always 
experiences a downward-pulling force, setting up the tension. 
 
 
 
 Lipid movements in the bilayer give rise to an internal pressure which may be as 
high as 400 atm in certain regions
15
.  The effect of bilayer lateral pressure can be 
observed in a pressure profile of the three regions (Figure 1.9)
15
. 
 
 
 
In the headgroup region there are both repulsive and attractive forces between the 
molecules.  Steric hindrance between molecules is a repelling force; electrostatic 
and hydrogen bonding forces are attractive.  The net pressure in this region is a 
positive (i.e. acting “outwards”), repelling lateral pressure, leading to bilayer 
expansion in this region.  In the glycerol region there is an attractive tension 
arising from the interactions between the tops of the acyl chains and water 
molecules; that is, the hydrophobic tops of the chains tend to pull together to 
avoid contact with water.  This produces a net negative (i.e. acting “inwards”), 
attractive lateral pressure, causing bilayer contraction in this region.  In the acyl 
chain region there are both repulsive forces (thermal motions) and attractive 
forces (van der Waals‟ interactions) in play; overall there is a net positive, 
repelling lateral pressure in this region, leading to bilayer expansion.  In general, 
the bilayer expands in the headgroup and acyl chain regions, pushing other 
bilayer molecules “outwards”, and contracts in the glycerol region, pulling 
molecules “inwards”10, 15 - 17.  The pressure profile in the acyl chain region is also 
dependent on chemical structure to an extent, and can be increased by the 
presence of double bonds
10
.   
 
 
 
 
 
Figure 1.9. Bilayer lateral pressure profile, indicating regions of headgroup 
interactions (green arrows), chain pressures (blue arrows), and interfacial tension 
(red arrows) 
 
 Part 3. Introduction to Lipid Domains  
 
The lipid heterogeneity of the classical Singer-Nicholson fluid mosaic model 
raises questions; a passive lipid matrix has no need for the variety of lipid 
structures and physical properties encountered in cell membranes.  The cell 
membrane is particularly enriched in cholesterol and sphingomyelin, both 
structurally rigid lipids involved in the formation of the lo phase.  It was 
hypothesised that the presence of cholesterol and sphingomyelin could lead to 
the formation of areas or „rafts‟ or lo phase lipids within the ld phase bulk
18
.  
Extraction of whole cells using cold, non-ionic detergents produces detergent-
resistant membranes (DRMs) enriched in cholesterol and sphingomyelin, and 
sometimes associated with certain proteins e.g. acylated proteins, 
glycophosphatidylinositol (GPI)-anchored proteins, and some receptor proteins.  
DRMs are a product of cold detergent extraction.  It is thought that the 
association of certain proteins with DRMs indicates a higher probability of 
association of these proteins with rafts in a cell membrane, making them useful 
indicators of possible “raftophilic” proteins19, 20.  Detergent extraction is not an 
ideal method; it relies on using detergents at low temperatures, which can 
produce an artificially high fraction of lo and gel phase lipids.  The use of 
alternative, room-temperature detergents may not solubilise all ld phase lipids.  
However it can be a useful technique when used in conjunction with other 
methods of extraction, which include the use of sodium carbonate gradients 
(which rely on pH) and immunoisolation
20
.   
 
Several roles for rafts have been proposed, based on the protein associations that 
have been discovered.  These include roles as platforms for protein-mediated 
events such as signal transduction, membrane fusion, organisation of the 
cytoskeleton, lipid sorting and protein trafficking
20
.  It is also thought that they 
may play a role in facilitating viral invasions and plaque formation during 
Alzheimer‟s disease.  Research has shown the co-localisation of psychotropic 
drugs with their receptors in rafts, implying that lipid rafts may play a role in co-
localising receptor proteins with their substrate molecules to facilitate and 
enhance signal transduction
21-23
.  Observing rafts in cell membranes poses more 
challenges than the analysis of microdomains in models, mainly due to their 
 small size (10 - 200 nm in diameter) and transient lifetimes.  One method is 
tracking the distribution of the fluorescent probe LAURDAN (6-dodecanoyl-2-
dimethylaminonaphthalene) in a membrane using two-photon microscopy
24
.  
 
Areas of lo/ld phase coexistence, termed lipid microdomains, may be observed in 
model membranes with the correct composition.  These are thought to be 
analogous to the biological rafts which form in the cholesterol- and sphingolipid-
enriched environment of the cell membrane.  Fluorescence quenching 
experiments have been used to show preferential partitioning of fluorophore 
molecules and quenching molecules into lo and ld phases, respectively, producing 
intense fluorescence for detection
12, 13, 25, 26
.  Microdomains can also be visualised 
indirectly using solid-state deuterium and proton NMR methods to show phase 
transitions and phase coexistence
14, 27-29
.  X-ray diffraction can be used to 
determine the thickness of bilayers, as microdomains are expected to be thicker 
than the surrounding liquid-disordered matrix
20
. 
 
Interactions between Lipids and Drug Molecules - Drug molecules must interact 
with a number of membranes on the way to their target receptor proteins.  If 
taken orally they must first cross from the digestive system to the blood vessels, 
and must then cross into the cell membrane to interact with membrane-situated 
receptors.  In addition, certain drugs must also cross the blood-brain barrier.  The 
majority of drug molecules then interact with a membrane protein, although 
lipid-soluble molecules may pass through the membrane without first interacting 
with a membrane protein or receptor.  Sargent and Schwyzer proposed the 
membrane catalysis mechanism of ligand/receptor binding, based on their 
observation of the interactions of the polypeptide hormones (adrenocorticotropin-
(1-24)-tetracosapeptide, ACTH1-24, and dynorphin-(1-13)-tridecapeptide, 
dynorphin1-13) with model membranes
30
.  In this mechanism, the final 
ligand/receptor binding step is preceded by accumulation of ligands in the 
membrane and interactions of ligands with membrane lipids.  Therefore, 
interaction of drug molecules with cell membranes is important to 
pharmacological activity.  Once in the cell membrane the drug molecule binds 
with the active site of its target protein.  In the case of agonist drugs the binding 
activates a cascade of signalling events within the cell, the results of which are 
 responsible for the drug‟s activity.  Therefore it is important for the interaction 
between the drug molecule and the receptor protein to be optimised.  The 
observation of certain receptor proteins isolated in detergent-resistant membranes 
has led to the hypothesis that signal transduction may be amplified by the co-
localisation of drug molecules with their receptor proteins
21, 31
.  Research has 
been carried out into the localisation of psychotropic drugs in detergent-resistant 
membranes
21,31
.  
 
Part 4. Membrane Proteins 
 
Introduction - Membrane proteins are a family of proteins that are defined by 
their relationship to biological membranes; they are not soluble in the aqueous 
environment of the cytoplasm and can only fold to the correct configuration 
when provided with a hydrophobic environment such as a biological membrane, 
artificial lipid bilayer or some detergent micelles.  Analysis of genome sequence 
data has predicted that membrane proteins may account for thirty to forty percent 
of the total protein complement of the cell
1, 15, 32-34
.  Despite this, information 
about their three-dimensional structures, folding behaviours, and interactions 
with the membrane is relatively scarce compared to the knowledge amassed 
regarding soluble proteins
1, 33, 34
. For example, known three-dimensional 
structures of water-soluble proteins number in their thousands, but less than one 
percent of the final structures in the Protein Data Bank are membrane proteins
1, 
32, 35-39
.   
 
Membrane proteins have a range of three-dimensional configurations and 
molecular weights.  They are categorised according to the level of their 
interaction with the membrane.  Peripheral membrane proteins are relatively 
loosely bound to either side of the cell membrane, facing out into either the 
cytoplasm or the exoplasm.  Integral membrane proteins (IMPs) may be 
amphipathic in nature, containing a hydrophobic, transmembranous domain and 
hydrophilic, extramembranous domains, which enables them to pass through the 
bilayer and extend on either side of the membrane.  IMPs are proteins that may 
only be extracted by disruption of the bilayer using detergents or organic 
solvents, while peripheral proteins are more readily extracted
8
. 
 The final three-dimensional structure of a membrane protein depends on the 
sequence of amino acids (the primary structure).  Chemical interactions between 
the amino acid side chains produce structures such as α-helices and β-pleated 
sheets.  Interactions between the α-helices and β-sheets of the same protein 
produce the final three-dimensional structure.  For enzymes, the final structure 
contains the active site.  The shape of the final folded enzyme is essential to its 
activity, because activity is conferred through the use of binding sites specifically 
suited to substrate molecules.  In addition proteins may incorporate intrinsic 
metal atoms as part of their three-dimensional structure, such as haemoglobin
40
. 
 
Roles of Membrane Proteins - The roles of membrane proteins include control of 
cell permeability, via channels, gates, pumps, and transporters; signal 
transduction across the membrane; energy generation; mediation of biosynthetic 
pathways; and catalysis.  They are also potential targets for pharmaceutical 
agents; in particular, for example G-coupled protein receptors (GPCRs), act as 
targets for the majority of drug molecules
1, 5, 35, 40, 41
. 
 
Membrane Protein/Lipid Interactions - The effects of lipids on membrane 
proteins are divided into specific and non-specific effects, and include both 
physical and chemical effects.  While the majority of the lipids in the membrane 
have a non-specific effect on proteins, it must also be considered that proteins 
themselves exert an effect on their neighbouring lipids; thus there are a number 
of mutual lipid-protein interactions governing the behaviour of membrane 
proteins
10
. 
 
The non-specific effects of lipids on membrane proteins arise from the molecular 
structures of phospholipids.  The effect of the interactions may be negligible, or 
may influence the folding and activity of the protein.  The effect of lipid 
dynamics, such as exchange, on membrane protein activity or folding is 
negligible.  Exchange from the lipids immediately surrounding the protein (the 
annular lipids) to the bulk does not alter the protein‟s lipid environment; these 
motions are sufficiently rapid relative to the timescale of protein motion that the 
protein experiences an average of the lipid motions.  Exchange of co-factor lipids 
occurs but is rare due to the strength of their interactions with the protein.  Other 
 physical properties, such as hydrocarbon chain length, have more of an effect on 
the protein
10
. 
 
Protein activity occurs at active sites, the structures of which are determined by 
the three-dimensional folding of the protein.  Hence proper function of the 
protein is highly dependent on its folded structure; misfolding of certain 
membrane proteins is known to contribute to several serious diseases, such as 
cystic fibrosis, Alzheimer‟s disease, and Creutzfeldt-Jakob disease42, 43.  The 
folded state is determined by the confines of the surrounding environment – the 
cell membrane.  Parameters such as lateral pressure and curvature stress would 
be expected to have a significant effect on insertion, folding and activity of 
membrane proteins. 
 
Protein transmembrane domains are subject to a range of forces in the bilayer.  
They exist under great pressure – the pressure in the bilayer has been calculated 
to reach several hundred atm in the acyl chain region
16
 – and under varying 
amounts of curvature frustration, depending on the composition of the 
membrane.  Both of these bulk physical properties have an affect on the 
insertion, folding and activity of membrane proteins
44-46
.  The effects can be 
studied by manipulating the degree of curvature frustration in a model 
membrane; a greater amount of PE lipids will increase the stored curvature 
elastic energy (SCEE), while a greater amount of single-chain or saturated PC 
lipids in an unsaturated PC lipid bilayer will decrease SCEE.  Research has 
shown that both increasing and decreasing SCEE can affect the protein.  For 
example, the folding yield of the membrane protein bacteriorhodopsin (bR) 
decreases when SCEE is increased by introducing greater amounts of PE lipids 
into a PC bilayer, and increases when SCEE is reduced by introducing single-
chain or short-chain PC lipids
47
.  It can be seen from these studies that there must 
be an optimum level of SCEE (and hence curvature frustration) for the insertion, 
folding and activity of membrane proteins, which may be controlled 
homeostatically by the cell itself
47
.  Since pressure in the bilayer is closely linked 
to membrane composition and curvature frustration, it may be expected that a 
similar feedback mechanism is utilised to provide the optimum pressure 
conditions for membrane proteins.  Protein activity is also affected by the acyl 
 chain length, with the optimum activity taking place in bilayers containing acyl 
chains eighteen carbon atoms in length; protein activity decreases when this 
length is exceeded or reduced
8
.  The acyl chain length is closely connected to 
hydrophobic mismatch.  The energetic cost of allowing either the hydrophobic 
acyl chains or the hydrophobic amino acid residues into contact with water is 
high, so the bilayer is expected to distort to match the span of the protein.  In fact 
the bilayer is not seen to distort as much as expected; instead there is a mutual 
deformation of the lipids surrounding the protein (by distortion of the acyl 
chains) together with the transmembrane domains (by changing the tilt angles or 
packing of the α-helices) (Figure 1.10)11. 
 
 
 
Figure 1.10. Diagram showing hydrophobic mismatch, and subsequent 
deformations of the lipid bilayer to reduce exposure of hydrophobic protein 
domains to the aqueous environment 
 
There are also specific, molecular interactions between lipid molecules and 
membrane protein domains.  The crystallisation of membrane proteins for x-ray 
crystallographic analysis has shown the presence of lipids bound to sites on the 
membrane protein.  These are known as non-annular lipids, and are thought to 
play a role in the activity of the protein
11, 16, 45
.  The interactions between the lipid 
molecule and the protein are strong enough to resist detergent solubilisation. 
 
Previous Analysis of Membrane Proteins - The most common method of 
obtaining high-resolution structural data from isolated water-soluble proteins is 
by x-ray diffraction of crystals, because these types of proteins are amenable to 
crystallisation; however this method has not been so extensively used to analyse 
membrane proteins.  The x-ray diffraction method first relies on the synthesis 
 and purification of relatively large amounts of protein, which is more difficult for 
membrane proteins.  While there are a large number of water-soluble proteins 
which can be first over-expressed and then purified from microbial hosts, the 
number of membrane proteins amenable to over-expression is limited.  In 
addition, they must also be provided with a suitable membrane-like environment 
in which to fold, which must not degrade over time.  Membrane proteins may be 
switched between a number of membrane model systems during a single 
purification route. 
 
Other methods of protein structural analysis include electron microscopy and 
NMR spectroscopy.  In previous years, NMR spectroscopy was hindered by the 
insolubility of membrane proteins in aqueous environments; however, the 
development of solid-state NMR spectroscopy, in combination with advances in 
NMR hardware and software, have led to this becoming an important method for 
structural and dynamical investigations of membrane proteins
48, 49
.  The 
production of membrane protein suffers from a number of problems.  Only 
relatively small proteins can be analysed, because protein over-expression can 
lead to aggregation within the host due to the lack of insertion machinery in 
prokaryotes; in addition, the protein can only be purified by partitioning into 
detergent micelles, which destabilises and degenerates the protein over time.  
Because of the reasons above, only a very small percentage of the fully 
elucidated protein structures available in the Protein Data Bank belong to 
membrane proteins; at the time of writing, only four hundred structures (seventy-
one of which were produced using NMR spectroscopic methods) out of a total of 
over seventy-two thousand belonged to membrane proteins
37
.  It is an important 
field which merits a great deal of research to overcome these experimental 
hurdles. 
 
Part 5. NMR Spectroscopy 
 
Introduction - Nuclear magnetic resonance (NMR) spectroscopy is a useful, 
versatile technique for the detection of molecular structure and composition that 
relies on measuring the interactions of nuclear magnetic fields with an applied 
magnetic field.  It can be used with liquid, solid or gas samples, with compounds 
 of various masses and compositions, and can be used to detect a wide range of 
nuclides depending on instrumentation.  It has been used in a diverse range of 
research areas, including organic, inorganic, and physical chemistry, medicine, 
biochemistry, protein science, and the food industry
50
. 
 
Background - All nuclei possess an intrinsic property known as spin, a form of 
intrinsic angular momentum, which may have an integral or non-integral value
50-
52
.  Nuclei also have an intrinsic magnetic moment, μ, which is linked to spin by 
Equation 1
51
: 
 
I   
 
Equation 1. Equation for the calculation of magnetic moment; where γ is the 
magnetogyric ratio; I is spin; and ћ is 2
h
 where h is Planck’s constant51 
 
The magnetogyric ratio varies between different species of nuclei; for example, 
the magnetogyric ratio of protons, γ1H = 26.7522 x 10
7
 rad s
-1
 T
-1
, is the largest 
magnetogyric ratio among commonly examined nuclei
51, 52
.  It determines the 
resonant frequency, ν, of a nucleus in a particular magnetic field strength51. 
 
In simple terms, a spin-½ nucleus (for example, the proton) may be regarded as a 
bar magnet with north and south poles.  In the absence of an external applied 
magnetic field, the spins may align in any possible direction, and all orientations 
are equally represented; the sample is in equilibrium
50
.  All of these possible 
orientations are degenerate
52
.  The application of a magnetic field, B0, breaks the 
degeneracy, and the spins align into (2I + 1) possible orientations.  For a spin-½ 
nucleus, therefore, there are two possible orientations: aligned parallel to the B0 
field, or aligned antiparallel to the B0 field
51, 52
.  The energy of the two possible 
energy states is quantised.  The allowed energies are given by the magnetic 
quantum number, mI, with values of –I, -I + 1, -I + 2…I – 1, etc.  Therefore, for a 
spin-½ nucleus the possible values of mI are –½ and +½.  The energy levels 
correspond to the parallel (lower energy) and antiparallel (higher energy) 
 orientations of the spins.  The difference between the energy levels is ΔE, where 
E is energy
32
.  The energy gap depends on the magnitude of the nuclear magnetic 
moment, μ (and hence on the magnetogyric ratio, from Equation 1) and on the 
strength of the external applied magnetic field, B0
32, 33
.  Since the energy of the 
interaction of the spins with the field is proportional to μ and B0, then
32
: 
 
01BmE   
 
Equation 2. Equation for the calculation of energy of the interaction between the 
spins and the magnetic field 
 
The energy difference, ΔE, between the two energy levels is then51: 
 
0BE   
 
Equation 3. Equation for the calculation of the energy difference between two 
energy levels when mI is 1; the minus sign has been dropped due to formality 
 
Using Planck‟s law, hE  , the difference in energy between the two 
orientations can be calculated in terms of frequency
51, 52
: 
 



2
0B  
 
Equation 4. Equation for the calculation of energy difference in terms of 
frequency; where ν is the frequency of nuclear precession about the B0 axis (in 
Hz) 
 
This frequency, ν, is known as the Larmor frequency.  The application of 
electromagnetic radiation of this frequency (using radiofrequency (RF) radiation) 
allows the spins to flip from one energy level to the other
52
.  However, the exact 
resonance frequency of a nucleus is a characteristic of its chemical environment, 
because the magnetic field experienced by the nucleus varies due to the shielding 
 and deshielding effects of neighbouring electrons and nuclei.  This is known as 
the chemical shift
52
. 
 
The populations of the energy levels are determined by the Boltzmann 
population distribution
51, 52
: 
 
kT
E
lower
upper
N
N 
 exp  
 
Equation 5. The Boltzmann distribution for the population of energy levels; 
where Nupper, lower is the populations of the spins in the upper and lower energy 
levels; k is the Boltzmann constant; and T is temperature 
 
As there is only a small difference in populations between the upper and lower 
energy levels, NMR spectroscopy is an inherently insensitive technique.  This 
sensitivity becomes worse for protons analysed using weak fields or for nuclei 
with lower magnetogyric ratios
52
. 
 
Signal Generation - The NMR spectrum is obtained by generating a pulsed RF 
field from a coil which is placed in a suitable arrangement around the sample.  
An oscillating current is passed through the coil, which generates an oscillating 
magnetic field of the correct frequency to excite the sample nuclei.  The excited 
nuclei then precess about the B0 axis at their individual resonance frequencies, 
producing an oscillating magnetic field.  This field induces an alternating current 
in a nearby receiver coil
52
.  The radiofrequency signals generated by the 
precessing nuclear magnetic moments are then processed by the computer 
software into the free induction decay (FID).  The FID, which is a time-domain 
spectrum, is transformed into the frequency-domain NMR spectrum using 
Fourier transformation. 
 
The NMR Spectrum - The resonance frequency, ν, of a particular nucleus is 
affected by its position in a molecule and by its neighbouring nuclei.  This is 
displayed on the NMR spectrum as the chemical shift
51
: 
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Equation 6. Equation for the calculation of chemical shift, δ, in parts per million 
(ppm); where ν0 is the Larmor frequency and ν is the resonant frequency of the 
particular nucleus 
 
The difference between the nucleus‟s resonant frequency and the Larmor 
frequency arises because of the electron cloud surround the nucleus
51, 52
.  The 
electron cloud induces its own magnetic field (electrons are also spin-½ particles) 
which opposes the B0 field.  The magnetic field experienced by the nucleus then 
becomes
51
: 
 
  10BBeff  
 
Equation 7. Equation for the calculation of the effective magnetic field (Beff) 
experienced by the nucleus; where ζ is the shielding constant 
 
The electron-generated field is proportional to B0; the stronger the external 
applied field, the greater the opposing electron-generated field.  Nuclei may also 
be affected by the electron clouds of neighbouring nuclei, which may have 
shielding (opposed to the B0 field), or deshielding (augmenting the B0 field) 
effects
52
. 
 
The NMR resonance of a particular atom is also affected by scalar coupling, 
which determines the splitting pattern.  Scalar coupling only takes place through 
directly bonded atoms (over a distance of no more than three chemical bonds) 
and is generated by the interactions of the electron clouds of bonded atoms
50
.  
Since it is not a through-space interaction, it can give information about the 
chemical bonds present in a compound.  For spin-½ nuclei, the number of 
splittings for each signal is equal to n + 1.  The number of splittings therefore 
indicates the number of protons in an adjacent group.  The distance (the coupling 
constant) between the splittings may also provide useful information about 
 aromatic protons
52
.  Coupling constants for protons separated by three bonds are 
used to determine the conformations of protein secondary structures (such as α-
helices and β sheets) by calculating characteristic dihedral angles between the 
amide and carboxylic acid groups of the peptide backbone.  The dihedral angle is 
calculated from the measured coupling constants using the Karplus equation
52
: 
 
 23 coscos CBAJ   
 
Equation 8.  Equation for the calculation of dihedral angles from measured 
coupling constants; where 
3
J is the three-bond spin-spin coupling constant; A, B, 
C are coefficients with the values 2 Hz, -1 Hz and 10 Hz, respectively; and θ is 
the dihedral angle
52 
 
NMR Experiments - There is a wide range of available NMR experiments, 
depending on what information is required about the sample and what 
instrumentation is present.  The most commonly used, and simplest, NMR 
experiments are the 1D proton 90° experiments routinely used in organic 
synthetic laboratories to quickly produce confirmation of structures of novel 
compounds.  1D carbon experiments such as DEPT experiments are also used to 
give structural information about the presence of primary, secondary, tertiary and 
quaternary carbon atoms.  Further structural detail can be obtained by using more 
advanced 2D experiments such as NOESY, COSY or HSQC.   
 
NMR is not limited to the measurement of carbon and hydrogen; technically any 
spin>0 element may be analysed, although in practice limitations with the 
available instrumentation may limit the possibilities.  Some other commonly 
measured nuclides include 
31
P, 
19
F, 
15
N and 
29
Si.  More complex spectra are 
generated by analysing quadrupolar nuclides such as 
2
H (or D) and 
14
N.   
 
2D NMR - In a simple 1D experiment, there is a single 90° RF pulse followed by 
an acquisition period, during which the FID is collected.  This process is 
expanded for 2D NMR.  The primary 90° pulse is followed by a delay (t1), before 
a secondary 90° pulse is applied and the FID acquired.  The program is then 
 repeated for a series of t1 values.  The data set is deconvoluted as normal using 
Fourier transformation to produce a 2D spectrum
50
.  2D NMR experiments, such 
as COSY (correlation spectroscopy) and NOESY (nuclear Overhauser effect 
spectroscopy) show hetero- and homonuclear spin-spin couplings as cross-peaks 
along a diagonal axis and enable structural elucidation of complex compounds 
that may not be possible using 1D NMR methods. 
 
The 2D-NOESY experiment relies on the nuclear Overhauser effect (nOe), 
which is the transfer of magnetisation from one spin to another in a 
hetero/homonuclear dipole.  The nOe is a distance-dependent, through-space 
interaction which can give information on structure and on interactions between 
different moieties in the same sample. 
 
Solid-State NMR Spectroscopy - The main difference between solution-state and 
solid-state NMR is the effect of anisotropic interactions, such as homo- and 
heteronuclear dipolar interactions, which are no longer averaged out due to the 
random molecular motions occurring in a liquid.  This random tumbling can be 
replicated by spinning the sample at an angle of 54.74° to the B0 axis, which is 
the average of the x, y and z axes. 
 
 
 
Figure 1.11 Diagram showing the position of a sample rotor with finned cap at 
54.7° to the B0 axis 
 
 Samples are loaded into rotors and fitted with finned caps, as shown in Figure 
1.11.  The caps are designed so that the rotor can be spun using currents of air.  
Spinning speeds are normally between 2.5 and 12 kHz. 
Since its invention, magic-angle spinning (MAS) has been used with a wide 
range of compounds, including catalysts, polymers and biomolecules
35
.  MAS-
NMR is well-suited to the analysis of native and model membranes, membrane 
proteins, and lipid/protein interactions
59-62
.  MAS produces resonance peaks with 
linewidths comparable to those of solution spectra, and allows the analysis of 
proteins in complex environments
57
.  Unlike solution-state spectroscopy, there is 
no upper limit to the molecular mass of proteins that may be analysed.  Despite 
the advantages of the ability to analyse a wide variety of compounds in various 
states, there are some drawbacks to the MAS technique.  The spectral resolution 
is worse than that found for solution-state NMR, and it requires greater amounts 
of sample due to the decrease in sensitivity
60
.  This problem may be overcome to 
a certain extent with the use of rotor inserts which help to position a small 
amount of sample at the correct position in the NMR coils to achieve results with 
maximum efficiency.  There may also be problems associated with localised 
heating of the sample due to high spinning speeds, and with non-uniform 
distribution of the sample due to high centrifugal forces.  There is also a loss of 
information on lipid conformations and dynamics in the bilayer due to the 
averaging out of anisotropic interactions.  The signal-to-noise ratio found with 
MAS may be improved using the cross-polarisation (CP) technique, which 
allows the transfer of polarisation from abundant spins (such as protons) to rare 
spins (
13
C or 
15
N, for example), thus improving detection of these rare nuclei
60
.  
The MAS experiment may be further improved by using high-power decoupling, 
which simplifies the spectrum by decoupling protons from rare nuclei. 
 
Dipolar Recoupling On-Axis with Scaling and Shape Preservation – DROSS is a 
NMR technique which measures 
13
C-
1
H dipolar couplings in solids.  The widths 
of the dipolar couplings are used to produce order parameter measurements using 
Equation 9
53
: 
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Equation 9. Equation for the calculation of order parameter using DROSS, 
where SCH is the 
13
C-
1
H order parameter, WCH is the width of the 
13
C-
1
H dipolar 
splitting, and χ is the scaling factor (equal to 0.393).  The WCH term is divided by 
20200 MHz in the case of methylene protons, and 20800 MHz in the case of 
vinylic protons
54
 
 
Equation 9 is derived from the equation used to calculate order parameter from 
deuterium NMR measurements
55
: 
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Equation 10. Equation for the calculation of order parameter using deuterium 
NMR, where ΔνQ is doublet spacing (equivalent to WCH), (e
2
qQ/h) is the static 
quadrupole splitting constant (equal to 20200 MHz for methylene 
13
C-
1
H dipolar 
splittings, and 20800 MHz for vinylic 
13
C-
1
H dipolar splittings), and SCD is the 
13
C-D order parameter
55
 
 
There are a number of advantages to the use of DROSS over other methods.  
There is no need for isotopic enrichment of samples; it has greater sensitivity and 
resolution than deuterium NMR; and it can be used to analyse natural abundance 
membranes, which is not possible for deuterium NMR
53, 56-58
.  However, the 
precision in the order parameter values calculated for deuterium NMR is higher 
than the values calculated for DROSS because the 
13
C-
1
H dipolar couplings are 
about an order of magnitude smaller than the deuterium quadrupolar coupling
58
.   
 
Deuterium (
2
H) NMR – Deuterium NMR is commonly used in the analysis of 
lipid membranes, films and liquid crystals
63
.  Deuterium is a spin-1 nucleus and 
has an electric quadrupole moment in addition to the nuclear magnetic moment.  
 The quadrupole moment interacts with the electric field gradients generated by 
the nucleus.  The nuclear electric field gradients are anisotropic and produce 
characteristic static powder patterns for non-crystalline samples known as Pake 
patterns.  Deuterium NMR is not usually carried out under MAS conditions.  The 
spectra may be de-Paked using various software programs to display the 
quadrupolar splittings for each resonance
48, 63
.  The main disadvantage of using 
deuterium NMR is the use of deuterated molecules, which may be expensive and 
difficult to synthesise; however, this technique can provide a wealth of structural 
and physical information.   
 
Part 6. Use of Isomerisable Lipid Analogues to Modulate Membrane 
Behaviour 
 
The modulation of membranes by inclusion of a non-perturbing molecule into a 
bilayer has potentially useful applications, such as drug release from liposomes 
enabling targeted drug delivery
64
.  Lipid analogues containing azobenzene 
moieties are suitable candidates for research, as their structure can be tailored to 
avoid bilayer perturbation by matching acyl chain lengths. 
 
Azobenzenes - The term „azobenzene‟ encompasses a class of molecules 
containing the following functional group (Figure 1.12): 
 
 
 
Figure 1.12. The azobenzene moiety in the trans configuration 
 
Where groups R and R‟ may be identical or non-identical.  The extended 
aromatic structure produces a strong optical absorption; for this reason, 
azobenzene-containing molecules are used in many dyestuffs and colourants
65
.  
The optical properties are due to an intense π-π* absorption band in the near-UV 
region, with a λmax of 318 nm and an extinction coefficient, ε, of 21000 M
-1
 cm
-1
, 
and a weaker, symmetry-forbidden n-π* absorption band in the visible region, 
 with a λmax of 433 nm and ε of 490 M
-1
 cm
-1
 for the azobenzene moiety in the 
trans configuration
66, 67.  In the cis configuration, the stronger π-π* absorption 
band shifts to 254 nm, with ε of 7 – 10 x 103 M-1 cm-1, while the extinction 
coefficient of the n-π* absorption band at 433 nm increases to 1500 M-1 cm-1[66, 
68, 69]
.  The absorption bands are shown in Figure 1.13: 
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Figure 1.13. The absorption bands of an azobenzene-containing compound in 
methanol, showing the allowed π-π* and forbidden π-n* transitions, and the 
difference between the cis and trans spectra 
 
Azobenzene moieties are shown (Figure 1.14) in the trans and cis configurations: 
 
 
 
Figure 1.14. The trans (E) and cis (Z) configurations of the azobenzene moiety 
 
 The planar trans state of the azobenzene molecule is shown on the left-hand side 
of Figure 1.14, while the non-planar cis state is shown on the right
64
.  
Azobenzenes undergo trans-to-cis isomerisation on irradiation with 360 nm-
wavelength light (in the UV region), and undergo cis-to-trans isomerisation on 
irradiation with 420 nm-wavelength light (in the visible region) or by thermal 
excitation
66, 70, 71
.  Trans-to-cis isomerisation results in a structural rearrangement 
as the distance between the p-carbon atoms decreases from 9 Å to 5.5 Å, and the 
dipole moment increases from 0 D to 3.0 D
65-67
.  The trans isomer is thermally 
stable while the cis isomer is metastable
67
. 
 
Azobenzene-containing molecules have many applications, including their use in 
photoresponsive molecular and supramolecular systems in the form of films, 
polymers or dyes
66, 67, 69, 71
, fluorescence probes
72
, optical storage media
65, 66
, and 
in the modification of oligonucleotides
73
.  They have also been used to control 
biological systems and mechanisms, such as membrane permeability to drugs
70-
79
.  The advantages of using azobenzene molecules include a high quantum 
efficiency of photoisomerisation which is easy and reversible, and no 
fluorescence or phosphorescence
65, 66, 77
.  Balasubramanian et al. observed that it 
was possible to alter the properties of model membrane containing embedded 
azobenzene molecules by illumination under the appropriate wavelength of light, 
and then found that this change altered the activity of an enzyme (α-
chymotrypsin) in the membrane
74
.  Further studies using specifically-synthesised 
lipid analogues containing azobenzene moieties showed that it was possible for 
them to form liposomes with lipid molecules such as DOPC or DPPC, which 
were then used to analyse ion leakage from the bilayer and the photoisomerisable 
control of bilayer permeability to trapped fluorescent molecules, and to 
investigate the possibility of using azobenzene-doped liposomes to release drug 
molecules to targets
64, 68, 71, 77
.  Folgering et al. used the photoisomerisation of 
azobenzene-containing lipid analogues in liposomes to affect the activity of the 
membrane protein MscL (mechanosensitive channel of large conductance)
80
.  
The use of azobenzenes allows a range of parameters, such as wavelength and 
intensity, to be adjusted during the course of an experiment without physical 
disruption
70, 77
.  Disadvantages include the possibility of packing or aggregation 
effects such as J-aggregation, in which the azobenzene molecules aggregate in a 
 „head-to-tail‟ arrangement, or H-aggregation, where the azobenzene molecules 
form a parallel arrangement
65, 76
.  J-aggregation has the effect of shifting the 
absorption maximum to a longer wavelength (red-shift) while H-aggregation 
shifts the absorption maximum to a shorter wavelength (blue-shift)
76
.  
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 Chapter 2: Modulation of Enzyme Activity Using an Azobenzene-
Containing Lipid Analogue 
 
Part 1. Introduction 
 
The research of Kaufman et al. and Bieth et al. showed that the 
photoisomerisation of an azobenzene-containing photochromic compound could 
effect a change in the activity of the enzymes chymotrypsin and 
acetylcholinesterase
1, 2
.   The research was expanded by Balasubramanian et al. 
with the addition of a model membrane into which α-chymotrypsin was 
incorporated
3
.  The photoisomerisation of an azobenzene compound in the model 
membrane was found to induce differences in electrical resistance and to alter the 
activity of chymotrypsin.  Both effects were theorised to be caused by the 
perturbation of the model membrane which took place when the azobenzene 
compound was switched from one isomer to the other
3
.    These results gave rise 
to the concept of control over certain biological processes, such as enzyme 
catalysis, by using photochromic compounds.  Sandhu et al. synthesised and 
characterised azobenzene-containing phospholipid analogues, which had one or 
both acyl chains replaced by an azobenzene-containing chain
4
.  The research 
demonstrated that the azobenzene phospholipids were able to form stable 
vesicles in isolation, and in combination with another phospholipid of 
comparable length (DPPC).  At low concentrations (< 5 % w/w) in a DPPC 
bilayer there were no signs of aggregation (although a previous study had shown 
some evidence of phase separation of azobenzene phospholipids at a 
concentration of 10 % w/w in a DPPC bilayer)
4, 5
.  Photoisomerisation of the 
monolayers induced large changes in molecular surface area
4
.   
 
Further research utilising the photochromic properties of azobenzene lipids 
involved the investigation into controlling solute leakage from liposomes and 
controlling the activity of a protein channel
6, 7
.  Azobenzene-containing lipids 
were investigated as a possible release mechanism for liposomes containing 
substances, which might provide a possible method for site-specific delivery of 
certain drugs
6
.  Photoisomerisation of azobenzene compounds in lipid bilayers 
 containing the MscL (mechanosensitive channel of large conductance) protein 
resulted in changes in protein activity
7
. 
 
Although azobenzene provide a relatively simple, non-invasive method of 
modifying both lipid bilayer properties and protein activity, the main 
disadvantage of their use is that of aggregation.  Both H- (parallel) and J-
aggregation („head-to-tail‟) lead to changes in the UV spectrum of the 
compound, and to phase separation of the azobenzene containing lipids from the 
phospholipid matrix
8, 9
. 
 
Diacylglycerol Kinase – Prokaryotic diacylglycerol kinase (DGK) is a 
membrane-based enzyme with a molecular mass of 13 kDa
10, 11
.  In E. coli, it is 
situated in the cytoplasmic membrane
12, 13
.  It contains 121 amino acid residues, 
making it a relatively small membrane protein
10, 14-16
.  It catalyses the reversible 
phosphorylation of diacylglycerol (DAG) to phosphatidic acid (PA) via the 
transfer of a phosphate group from MgATP to leave MgADP
10 – 12, 14 - 16
.  DGK is 
associated with the synthesis of carbohydrates and the synthesis of lipids used in 
the maintenance of the bacterial cell wall
13
. 
 
DGK consists of two cytoplasmic α-helices (amino acid residues 1 – 34, and 69 – 
95) and three transmembrane (TM) domains (amino acid residues 35 – 48, 52 – 
68, and 96 – 117)10, 11.  The functional form is homotrimeric with three active 
sites
11
.  It is an ideal candidate for analysis because it is relatively small for an 
integral membrane protein; it is tolerant to amino acid sequence mutations; and it 
is stable to expression and refolding into membrane mimetics such as 
liposomes
10, 13
.  It is naturally present in E. coli, which makes it amenable to 
overexpression.  These properties meant that it was one of the first integral 
membrane proteins to be purified and characterised.  
 
Part 2. Aims 
 
The aim was to synthesise a photoisomerisable lipid analogue according to the 
synthetic route by Song et al., which could then be incorporated into lipid 
vesicles
17
. 
  
The target compound was designed to have an effective length matching those of 
DOPC molecules, so that it could be incorporated into DOPC liposomes without 
leading to hydrophobic mismatch.  It was also designed to mimic the typical 
structure of a phospholipid molecule in order to attribute any observable changes 
in the behaviour of the lipid bilayer solely to the photoisomerisation of the 
azobenzene moieties, rather than to the presence of structurally incompatible 
molecules.  The target compound therefore contains a phosphocholine headgroup 
(chemically identical to the DOPC headgroup), a glycerol backbone, and two 
hydrocarbon tails; the most significant difference between the target compound 
and DOPC is the presence of the photoisomerisable azobenzene moieties.  The 
cis and trans states of the azobenzene lipid analogue are shown (Figure 2.1). 
 
 
 
Figure 2.1. The trans (E) and cis (Z) states of a photoisomerisable azobenzene-
containing phospholipid analogue 
 
Enzyme activity assay experiments on liposomes containing an azobenzene lipid 
analogue were carried out with the aim of assessing the difference between the 
activity of DGK when the photoisomerisable lipid is in the trans state compared 
 to when it is in the cis state.  It is hypothesised that the cis state isomers will 
affect the activity of the enzyme due to compression of the lipid bilayer, since the 
cis state isomers occupy more space in the bilayer than those in the trans state.  
Therefore a series of enzyme activity assays should demonstrate a difference in 
activity depending on the state of the photoisomerisable lipid analogues. 
 
In order to accomplish the enzyme activity assay experiments, a 
photoisomerisable azobenzene-containing lipid analogue was first synthesised.  
 
Part 3. Experimental 
 
Materials - 1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC) was purchased 
from Avanti Polar Lipids (Alabaster, AL).  4-(4-Heptylphenylazo)phenol and 6-
[4-(4-Heptylphenylazo)phenoxy]hexanoic acid (referred to in the text as 
azobenzene compounds 1 and 2, respectively) were gifts from H. Schwalbe of 
Goethe University, Frankfurt.  DBG was a gift from P. J. Booth of the University 
of Bristol. 
 
1,3-Bis(6-4-((E)-(4-butylphenyl)diazenyl)phenoxy)hexanoyloxy)propan-2-yl-2-
(trimethylammonio)ethyl phosphate (referred to in the text as bis-Azo-PC) was 
synthesised as described.  Lactate dehydrogenase-pyruvate kinase was purchased 
from Roche.  All other chemicals were purchased from Sigma. 
 
Synthesis of bis-Azo-PC - Two possible synthetic routes were considered.  The 
synthetic route by Song et al. was chosen in favour of that of Morgan et al. due 
to the lack of the necessary apparatus
4, 5, 17
.  There are two significant differences 
between the routes.  The steps prior to the synthesis of the crude anhydride is 
different in each route (a diazotisation followed by a Williamson etherification in 
the case of Song et al., and an acid oxidation and catalytic hydrogenation 
followed by diazotisation in the case of Morgan et al.), which leads to a slightly 
different final structure of the azobenzene phospholipid compound; the 
phospholipid compounds produced by following the route of Song et al. contain 
an additional ether oxygen atom
4, 5, 17
.  However both routes produce 
 azobenzene-containing phospholipid analogues to a length which may be 
dictated by the choice of starting materials. 
Synthesis of 4-((4-Butylphenyl)diazenyl)phenol – The reaction scheme is shown 
in Figure 2.2. 
 
 
 
Figure 2.2. Diazotisation of butylaniline 1 
 
HCl (10 mL, 36% w/w, 0.12 mol) was added slowly to a stirred solution of 4-n-
butylaniline 1 (5.96 g, 0.040 mol) in acetone:water (1:1, 100 mL).  After cooling 
to 0C, a cooled solution of sodium nitrite (2.9 g, 0.042 mol) in water (50 mL) 
was added.  The resulting solution was stirred for 15 min.  The solution was then 
added to a cooled, stirred solution of phenol (4 g, 0.043 mol), sodium hydroxide 
(1.7 g, 0.043 mol) and sodium carbonate (7 g, 0.066 mol) in water (100 mL).  On 
addition a bright yellow solid was formed, which was then filtered off.  The 
product was purified by recrystallisation from minimum amounts of 
toluene:hexane (1:1, x 3) to give 4-((4-butylphenyl)diazenyl)phenol 2 (3.22 g, 
32%) as orange crystals. 
 
Characterisation Data - Rf [chloroform:methanol (9:1)] 0.53; max (CHCl3) cm
-1
 
3018 (OH, s), 1525 (trans ar. N=N str., w), 1477 (cis ar. N=N str., w-m) and 
1424 (cis ar. N=N str., w-m); H (400 MHz; CDCl3) 7.86 (2H, ddd, J 8.98, 3.12 
and 2.10, 2 x CHCN; ArOH), 7.79 (2H, ddd, J 8.43, 2.20 and 2.02, 2 x CHCN; 
Ar), 7.30 (2H, ddd, J 8.43, 2.20 and 2.02, 2 x CH; Ar), 6.94 (2H, ddd, J 8.98, 
3.12 and 2.10, 2 x CHCO; ArOH), 5.30 (1H, brs, OH), 2.68 (2H, dd, J 7.70 and 
7.70, CH2CH2CH2CH3), 1.68 – 1.59 (2H, m, CH2CH2CH2CH3), 1.38 (2H, 
sextuplet, J 7.51, CH2CH2CH2CH3) and 0.94 (3H, t, J 7.33, CH2CH2CH2CH3); C 
(100 MHz; CDCl3) 158.2 (COH; ArOH), 150.9 (CN; Ar), 147.2 (CN; ArOH), 
 145.9 (C-CH2CH2CH2CH3; Ar), 129.0 (2 x CH; Ar), 124.8 (2 x CHCN; ArOH), 
122.6 (2 x CHCN; Ar), 115.7 (2 x CHCO; ArOH), 35.5 (CH2CH2CH2CH3), 33.4 
(CH2CH2CH2CH3), 22.3 (CH2CH2CH2CH3) and 13.9 (CH2CH2CH2CH3); found 
M
+
, 254.2; C16H18N2O requires 254.3; m/z 254.2 (40%, M
+
), 133.2 (55, 
CH3CH2CH2CH2C6H4
+
), 121.1 (60, N=NC6H4OH
+
) and 93.1 (100, C6H4OH
+
); 
m. p. 81.8 C 
 
Synthesis of 6-(4-((4-Butylphenyl)diazenyl)phenoxy)hexanoic acid – The reaction 
scheme is shown in Figure 2.3. 
 
 
 
Figure 2.3.  Etherification of 4-((4-butylphenyl)diazenyl)phenol 2 
 
A solution of 4-((4-butylphenyl)diazenyl)phenol 2 (4.50 g, 0.02 mol), 6-
bromohexanoic acid (4.0 g, 0.02 mol) and sodium  hydroxide (1.6 g, 0.04 mol) in 
ethanol (120 mL) was refluxed for 8 hr.  The resulting precipitate was filtered off 
under vacuum.  The precipitate was suspended in water (150 mL) and acidified 
with dilute HCl.  The resulting solution was separated into diethyl ether (100 mL; 
x 3) and the solvent removed.  The product was dried using a vacuum pump to 
give 6-(4-((4-butylphenyl)diazenyl)phenoxy)hexanoic acid 3 (1.18 g, 36%) as a 
yellow solid. 
 
Characterisation Data - Rf [methanol] 0.73; max (CHCl3) cm
-1
 3020 (OH, s), 
1524 (trans ar. N=N str., w), 1476 (cis ar. N=N str., w-m) and 1426 (cis ar. N=N 
str., w-m); H (400 MHz; CDCl3) 7.89 (2H, ddd, J 8.98, 3.12 and 2.02, 2 x 
CHCN; ArO), 7.79 (2H, ddd, J 8.25, 1.65 and 2.02, 2 x CHCN; Ar), 7.30 (2H, 
ddd, J 8.25, 1.65 and 2.02, 2 x CH; Ar), 6.94 (2H, ddd, J 8.98, 3.12 and 2.02, 2 x 
CHCO; ArO), 4.05 (2H, t, J 6.42, HOOCCH2(CH2)3CH2O), 2.68 (2H, dd, J 7.70 
and 7.70, CH2CH2CH2CH3), 2.42 (2H, t, J 7.33, HOOCCH2(CH2)3CH2O), 1.86 
(2H, quintuplet, J 7.15, -CH2-), 1.75 (2H, quintuplet, J 7.88, -CH2-), 1.68 – 1.53 
 (4H, m, -CH2-), 1.38 (2H, sextuplet, J 7.51, CH2CH2CH2CH3) and 0.94 (3H, t, J 
7.42, CH2CH2CH2CH3); C (100 MHz; CDCl3) 177.0 (HOOC), 161.3 (COH; 
ArO), 151.0 (CN; Ar), 145.9 (CN; ArO), 145.8 (C-CH2CH2CH2CH3; Ar), 129.1 
(2 x CH; Ar), 124.6 (2 x CHCN; ArO), 122.6 (2 x CHCN; Ar), 114.7 (2 x 
CHCO; ArO), 67.9 (HOOCCH2(CH2)3CH2O), 35.6 (CH2CH2CH2CH3), 33.5 
(CH2CH2CH2CH3), 28.9 (HOOCCH2(CH2)3CH2O), 25.6 
(HOOCCH2(CH2)3CH2O), 24.4 (HOOCCH2(CH2)3CH2O), 22.3 (CH2CH2CH-
2CH3) and 13.9 (CH2CH2CH2CH3); found M
+
, 368; C22H28N2O3 requires 368.3; 
m/z 368 (3%, M
+
), 194 (13, C6H4-N=N-C6H4O
+
), 180 (3, C6H4-N=N-C6H4
+
), 148 
(3, CH3CH2CH2CH2-C6H4-NH
+
), 133 (3, CH3CH2CH2CH2-C6H4
+
), 91 (44, N-
C6H4
+
) and 44 (100, COO
+
); m. p. 147.5C; crystalline, 147.5C [nematic phase, 
136.0C] isotropic 
 
Synthesis of 6-(4-((4-Butylphenyl)diazenyl)phenoxy)hexanoic pivalic anhydride – 
The reaction scheme is shown in Figure 2.4. 
 
 
 
Figure 2.4. Synthesis of the crude anhydride 4 
 
A solution of 6-(4-((4-butylphenyl)diazenyl)phenoxy hexanoic acid 3 (0.46 g, 
1.26 x 10
-3
 mol) in dichloromethane (20 mL) was stirred for 30 mins under 
nitrogen to remove moisture.  Following this pivaloyl chloride (1.2 mL, 9.76 x 
10
-3
 mol) and triethylamine (0.4 mL, 2.87 x 10
-3
 mol) were added, and the 
reaction mixture was left to stir for 20 h.  The solvent was removed and the 
product was dried on a vacuum pump to give the crude anhydride 4 (0.92 g) as a 
yellow solid.   
 
The crude anhydride was used in the acylation step with no further work-up; for 
this reason, there is no available characterisation data. 
 
  
 
Synthesis of 1,3-bis(6-4-((E)-(4-Butylphenyl)diazenyl)phenoxy)hexanoyloxy) 
propan-2-yl 2-(trimethylammonio)ethyl phosphate (bis-AzoPC) – The reaction 
scheme is shown in Figure 2.5. 
 
 
 
Figure 2.5. Acylation of crude anhydride 4 to produce the azobenzene-containing 
lipid analogue 5 
 
A solution of crude anhydride 4 (0.92 g) in dichloromethane (20 mL) was added 
to a suspension of glycerophosphorylcholine as the cadmium chloride complex 
(0.26 g, 6 x 10
-4
 mol) and dimethylaminopyridine (0.14 g, 1 x 10
-3
 mol) in 
dichloromethane (20 mL) after both solutions were stirred under nitrogen to 
remove excess moisture.  The reaction mixture was left to stir for 24 h.  It was 
filtered through a sinter to remove solid residue.  The solvent was removed and 
the solid redissolved in solvent A (chloroform:methanol:water, 65:25:4) and 
passed through an Amberlite column to remove any remaining impurities.  The 
solvent was removed and the solid was redissolved in a minimum amount of 
dichloromethane and tetrahydrofuran to encourage crystallisation.  The yellow 
precipitate 5 was filtered off (120 mg). 
 
 
  
Characterisation Data - δH (400 MHz; CDCl3) 7.86 (4H, ddd, J 8.98, 2.93 and 
2.02, 2 x CHCN; ArO), 7.78 (4H, ddd, J 8.25, 1.65 and 2.02, 2 x CHCN; Ar), 
7.28 (4H, ddd, J 8.25, 1.65 and 2.02, 2 x CH; Ar), 6.94 (4H, ddd, J 8.98, 2.93 and 
2.02, 2 x CHCO; ArO), 5.27 – 5.22 (1H, m, (CH3)3N
+
CH2CH2OPO2
-
OCH(CH2O)2), 4.45 – 4.34 (2H, m, (CH3)3N
+
CH2CH2OPO2
-
OCH(CH2O)2), 4.18 
– 4.13 (1H, m, (CH3)3N
+
CH2CH2), 4.00 (6H, quintuplet, J 6.23, CH2O(CH2-
)3CH2COO), 3.77 (2H, br. s., (CH3)3N
+
CH2CH2), 3.31 (8H, s, 
(CH3)3N
+
CH2CH2), 2.66 (4H, t, J 7.70, CH2CH2CH2CH3), 2.37 – 2.27 (5H, m, 
CH2O(CH2)3CH2COO), 1.85 – 1.75 (4H, m, CH2O(CH2CH2CH2)CH2COO), 1.71 
– 1.59 (9H, m, CH2CH2CH2CH3), 1.54 – 1.43 (5H, m, 
CH2O(CH2CH2CH2)CH2COO), 1.37 (4H, sextuplet, J 7.51, CH2CH2CH2CH3) 
and 0.94 (7H, t, J 7.33, CH2CH2CH2CH3); C (100 MHz; CDCl3) 173.3 (CH-
2O(CH2)3CH2COO), 161.3 (CO: ArO), 151.0 (CN; Ar), 147.0 (C-CH2CH-
2CH2CH3; Ar), 145.8 (CN; ArO), 129.1 (2 x CH; Ar), 124.6 (2x CHCN; ArO), 
122.5 (2 x CHCN; Ar), 114.6 (2 x CH; ArO), 70.7 ((CH3)3N
+
CH2CH2OPO2
-
OCH(CH2O)2), 68.0 (CH2O(CH2)3CH2COO), 66.6 ((CH3)3N
+
CH2CH2), 63.5 
((CH3)3N
+
CH2CH2OPO2
-
OCH(CH2O)2), 59.3 ((CH3)3N
+
CH2CH2OPO2
-
OCH(CH2O)2), 54.6 ((CH3)3N
+
CH2CH2), 35.6 (CH2CH2CH2CH3), 34.0 (CH-
2O(CH2)3CH2COO), 33.5 (CH2CH2CH2CH3), 28.9 (CH2O(CH2-
CH2CH2)CH2COO), 25.6 (CH2O(CH2CH2CH2)CH2COO), 25.0 (CH2O(CH2-
CH2CH2)CH2COO), 22.4 (CH2CH2CH2CH3) and 13.9 (CH2CH2CH2CH3); found 
M
+
, 958.4; C52H72N5O10P requires 958.1; m/z 958.4 (100%, M
+
), 959.4 (55, M + 
[H]
+
) and 980.2 (30, M + [Na]
+
); m. p. 168 C; crystalline, 168.0 C [Smectic C, 
185.0 C] [Smectic A, 197.2 °C] isotropic. 
 
Protein Synthesis – The procedure for the synthesis of DGK was followed from  
Lau and Bowie
17
.  Plates prepared with agar, LB growth medium (prepared using 
10 gL
-1
 tryptone, 5 gL
-1
 yeast extract and 10 gL
-1
 sodium chloride in distilled 
water, pH adjusted to 7.5) and 0.1 μgL-1 ampicillin were streaked with E. coli 
from a previously prepared strain (strain BL21, containing the pSD004 plasmid, 
a gift from C. Sanders at Vanderbilt University) and incubated at 37 °C 
overnight.  Sample bottles of 5 mL LB growth medium containing ampicillin 
 were then inoculated with colonies picked from the agar plates and incubated 
overnight at 37 °C with shaking.  The samples were then transferred to 0.5 L of 
LB growth medium in 2 L flasks, with ampicillin and were incubated at 37 °C 
with shaking.  The growth of the bacteria was monitored using UV/vis 
spectrophotometry at A600.  Isopropyl-β-D-thiogalactopyranoside (IPTG) was 
added when the absorbance of the bacteria suspension reached 0.8 AU in order to 
activate the correct promoter section of the gene (the lac operon) on the plasmid 
and induce DGK expression.  Samples were harvested at stages (30 min, 60 min, 
120 min and 180 min) to monitor the progress of DGK expression using 
polyacrylamide gel electrophoresis (PAGE) and then incubated at 37 °C 
overnight. 
 
SDS-PAGE – The harvested samples were pelleted and resuspended in gel 
loading buffer (sodium dodecyl sulphate (SDS) in 2-mercaptoethanol).  The 
SDS-PAGE apparatus was set up and loaded with the separating gel, which 
resolves the protein (prepared using 4 mL glycerol, 3 mL 30% acrylamide, 2 mL 
distilled water, 20 μL ammonium persulphate (APS) and 75 μL N,N,N’,N’-
tetramethylethylenediamine (TEMED) in 10 mL TRIS base (2 M 
tris(hydroxymethyl)aminomethane (TRIS base) in distilled water, pH adjusted to 
6.8) and the stacking gel (prepared using 1 mL acrylamide, 3.4 mL distilled 
water, 20 μL APS, 75 μL TEMED and 1.2 mL TRIS base, prepared as described 
previously).  The tank was loaded with the anode and cathode buffers (anode 
buffer, prepared using 2 M tris(hydroxymethyl)aminomethane (TRIS base) in 
distilled water, pH adjusted to 8.9; and cathode buffer, prepared using 0.1 M 
TRIS base, 0.1 M tricine, and 0.1 % w/v SDS in distilled water).  The gels were 
then loaded with samples in addition to a lysozyme marker and the PAGE was 
run.  Following the completion of the separation, the gels were recovered, stained 
with a triphenylmethane dye, Coomassie Brilliant Blue R-250 
(C45H44N3NaO7S2), and destained with a solution of 45 % methanol, 45 % 
distilled water, and 10 % glacial acetic acid. 
 
Extraction of DGK – Cells were pelleted from the flasks by high speed, low 
temperature ultracentrifugation for 15 mins at 4°C, at a speed of 5000 rpm (6440 
x g) using a Sorvall RC-5B Superspeed centrifuge.  The cell paste was then 
 resuspended in buffer A (prepared using 50 mM sodium phosphate and 300 mM 
sodium chloride in distilled water, pH adjusted to 7.5).  1 mM 
phenylmethylsulphonyl fluoride (PMSF) solution was added to protect the target 
protein DGK from attack by other proteins from the lysed bacteria.  The 
detergent n-octyl-β-D-glucopyranoside (OG) was also added to a concentration 
of 3 % w/v, and the suspension stirred at 4 °C. 
 
The suspension was then pelleted by centrifugation at a speed 5000 rpm and a 
temperature of 4 °C, giving a typical yield of pelleted material.  The protein was 
suspended in 40 mL buffer A plus 1.5% OG and loaded onto a nickel-NTA-
agarose resin column washed with buffer A.  The protein was eluted off the 
column using buffer A containing 0.02 M imidazole and 0.5% n-decyl-β-D-
maltopyranoside (DM).  The presence of protein in each fraction was confirmed 
using SDS-PAGE.  The results of the SDS-PAGE procedure can be found in the 
Results and Discussion section.  The protein was stored as a detergent solution at 
-80 °C until use.   
 
Preparation of Liposomes - Samples of DOPC/azobenzene compound were 
prepared at molar ratios of 9:1.  The typical amount of DOPC used in each 
experiment was approx. 80 mg.  The lipids were co-dissolved in 
chloroform/methanol (1:1 v/v).  The solvents were evaporated under vacuum, 
and the resulting lipid cake was suspended in 1 mL of doubly distilled water, 
frozen in liquid nitrogen, and then lyophilised overnight under high vacuum.  
Samples were then rehydrated with either distilled water (for UV spectroscopy) 
or PIPES buffer (prepared using 75 mM 1,4-piperazine-bis(ethanesulphonic acid) 
(PIPES), 50 mM lithium chloride, 0.1 mM ethylenediaminetetraacetic acid 
(EDTA) and 15 mM magnesium chloride in distilled water, pH adjusted to 6.8; 
used for enzyme assay experiments), and extruded to produce 0.2 μm unilamellar 
liposomes. 
 
UV Spectroscopy – Samples were made up in 1 mL quartz cuvettes with an 
appropriate solvent.  The cis state was induced by irradiation at 350 nm, while 
the trans state was induced by irradiation at 440 nm using a mercury arc lamp at 
250 W.  Samples were typically irradiated for 15 mins.  Experiments were 
 carried out at 10 °C.  The blanks used matched the solvents used during each 
experiment. 
 
Enzyme Assay - The basic scheme of the enzyme activity assay is shown in 
Figure 2.6
19
. 
 
 
 
Figure 2.6. Enzyme activity assay schematic.  Abbreviations used are as follows: 
DBG (dibutyryl glycerol); DGK (diacylglycerol kinase); DBGP (phosphorylated 
DBG); ATP (adenosine triphosphate); ADP (adenosine diphosphate); PEP 
(phosphoenolpyruvate); PK (pyruvate kinase); LDH (lactate dehydrogenase) 
NADH (nicotinamide adenine dinucleotide); NAD
+
 (oxidised NADH) 
 
The enzyme DGK, synthesised by E. coli, phosphorylates diacylglycerols (DAG) 
using adenosine triphosphate (ATP).  In this assay dibutyryl glycerol (DBG) is 
used, as it is water-soluble and so the concentration can be easily controlled.  In 
the first step, DGK phosphorylates DBG to DBGP using ATP, producing 
adenosine diphosphate (ADP).  ADP from this step is then used in the catalysis 
of phosphoenolpyruvate (PEP) by the enzyme pyruvate kinase (PK), producing 
pyruvate and ATP.  Pyruvate then acts as a substrate for the action of the enzyme 
lactate dehydrogenase (LDH), which produces lactate using nicotinamide 
adenine dinucleotide (NADH).  NADH is transformed into NAD
+
 during the 
reaction.  NADH absorbs at a wavelength of 340 nm, while NAD
+
 does not 
absorb in the UV/visible region.  Therefore the entire reaction can be followed 
using UV-visible spectroscopy.  The conversion of NADH to NAD
+
 results in a 
 negative slope as NADH is turned over, with the gradient providing a measure of 
the enzyme activity
19
. 
 
Samples for enzyme assay were typically made up in 270 μL volume quartz 
cuvettes with a 1 cm pathlength as follows: 250 μL of assay mix (0.5 nM NADH, 
3 mM ATP, 3 mM DBG and 1 mM PEP in PIPES buffer), 10 μL of enzymes and 
10 μL of liposomes (synthesised as described above), either DOPC or 
azobenzene-containing DOPC, followed by the addition of DGK immediately 
prior to the experiment.  Experiments were typically carried out at 30 °C. 
 
Calculation of Enzyme Activity – The enzyme activity is derived from the 
gradient of the slope, which is an indicator of the rate of change of absorption per 
minute.  First of all the concentration of NADH, which has an extinction 
coefficient of 6440 mol L
-1
, is calculated from the gradient using the Beer-
Lambert equation (Equations 11 and 12).  The volume of the reaction mixture is 
then calculated in order to express the amount of NADH in moles in the cuvette 
(in units of μmol), followed by the amount of protein in mg.  When the rate of 
NADH turnover is divided by the amount of protein present, the resulting figure 
is a measure of specific enzyme activity, in units of μmol min-1 mg-1.  This figure 
is expected to change in relation to the conditions in the bilayer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 A number of azobenzene compounds were analysed during the series of 
experiments.  These are referenced as shown in Table 2.1. 
 
 
Table 2.1. Table showing the azobenzene compounds analysed 
 
Reference Name Chemical Structure and Name 
Azo compound 1 
 
 
4-(4-Heptylphenylazo)phenol 
Azo compound 2 
 
6-[4-(4-Heptylphenylazo)phenoxy]hexanoic acid 
 
Bis-Azo-PC 
 
 
1,3-Bis(6-4-((E)-(4-butylphenyl)diazenyl) 
phenoxy)hexanoyloxy)propan-2-yl 
2-(trimethylammonio)ethyl phosphate 
 Part 4. Results and Discussion  
 
Protein Synthesis – Fractions eluted from the nickel-NTA-agarose column were 
analysed using SDS-PAGE to determine the final concentration of DGK.  After 
destaining, two fractions (4 and 5) out of fourteen in total were observed to 
contain protein.  UV/vis spectrophotometry at A280 was used to analyse the 
concentrations of protein in both fractions.  The solution from fraction 4 was 
diluted 100-fold to produce an absorption of 0.13 AU.  The Beer-Lambert law 
was used to calculate the concentration of this fraction (Equation 11): 
 
cA   
 
Equation 11. Beer-Lambert law for the calculation of concentration from 
absorbance, where A is absorbance (AU), ε is the extinction coefficient (mg mL-1 
cm
-1
), c is concentration (mg mL
-1), and ℓ is the pathlength of the cuvette (cm) 
 
The use of a cuvette with a 1 cm pathlength leaves a rearranged equation for 
concentration (Equation 12): 
 

A
c   
 
Equation 12. Rearranged Beer-Lambert law for the calculation of concentration 
 
The extinction coefficient of DGK is 1.8 mg mL
-1
 cm
-1
.  Using the rearranged 
Beer-Lambert equation (Equation 12), the total concentration of the fractions was 
7.39 mg mL
-1
.   
 
Changing the conformation of azobenzene-containing compounds in solvents – 
The first step in the experiment was carried out in order to demonstrate that bis-
Azo-PC could change conformations while dissolved in a suitable solvent.  The 
experiments were first carried out on azobenzene compounds 1 and 2. 
 
 
 Azobenzene 2 was dissolved in methanol and analysed (Figure 2.7). 
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Figure 2.7. Trans state (black) vs cis state (red) of azobenzene compound 2 in 
methanol 
 
Figure 2.7 shows the cis and trans spectra for the sample of azobenzene 
compound 2 in methanol.  The plot gives a π-π* transition of 350 nm for the 
trans state (345 nm for the cis state) and an n-π* transition of ~ 440 nm for both 
states.  The absorbance of the ground state at λmax is higher than for the cis state, 
while the opposite is noted for the n-π* transition.    The isosbestic point occurs 
at approx. 420 nm.  These changes in the spectra show the difference between an 
induced cis state and the trans state. 
 
The analysis was also carried out on a sample of azobenzene 1 in methanol, but 
attempts to change the conformation failed, possibly due to tautomerism of the 
sample in solution.  Tautomerism of hydroxyl moieties was also discussed in a 
study carried out by Liu et al. on azobenzene-containing cholesterol compounds 
in liposomes.  The study found that a cholesterol compound terminating in a 
hydroxyl group was difficult to photoisomerise
20
. 
 
 
 
 The analysis was then carried out on a sample of bis-Azo-PC.  Figure 2.8 shows 
the cis and trans spectra of bis-Azo-PC in methanol. 
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Figure 2.8. Trans state (red) vs. cis state (black) of bis-Azo-PC  
in methanol 
 
The plot gives a π-π* transition of 349.04 nm for the trans state (342.97 nm for 
the cis state), and an n-π* transition of approx. 438 nm (~ 440 nm for the cis 
state).  The absorbance at λmax is much higher for the trans state than for the cis 
state, while the opposite is noted for the n-π* transition.  The isosbestic point 
occurs at approx. 410 nm. 
 
The π-π* and n-π* transitions typically found for the spectra agree with the 
wavelengths found for typical azobenzene compounds in literature: approx. 350 
nm for the π-π* transition and approx. 450 nm for the n-π* transition17. 
 
Changing the conformation of azobenzene-containing compounds in liposomes – 
After demonstrating that bis-Azo-PC was amenable to photoisomerisation in 
solvents, the next step was to incorporate it into DOPC liposomes to establish if 
it could be photoisomerised as part of a liposome.  A sample of DOPC/bis-Azo-
PC liposomes in distilled water was analysed (Figure 2.9). 
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Figure 2.9. Plot showing the trans state (red) vs. the cis state (black) of DOPC 
liposomes containing bis-Azo-PC 
 
The plot shows a considerable difference between the absorption spectra of bis-
Azo-PC in methanol and those of DOPC/bis-Azo-PC liposomes.  Figure 2.10, a 
comparison of the cis state spectra for each compound, shows that the π-π* 
transition has shifted from ~ 350 nm for the pure azobenzene compound to ~ 320 
nm for the liposomes.  The overall profile of the spectrum has also changed, with 
the presence of a slope followed by the loss of a visible n-π* transition peak.  
Figure 2.9 shows the presence of two isosbestic points (at ~ 340 nm and ~ 390 
nm), in comparison to the single isosbestic point observed for pure azobenzene. 
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Figure 2.10. Plot showing the difference between the cis states of bis-Azo-PC in 
methanol (red) and bis-Azo-PC incorporated into DOPC liposomes (black), 
measured in H2O 
 
The comparison of the spectra of the pure azobenzene compound against the 
DOPC/bis-Azo-PC liposomes shows that the presence of liposomes hinders the 
ability to visually separate the two states, as the difference between the trans and 
cis states is not as clear as it is between the states of the pure azobenzene 
compound.  There may also be negative effects from the turbidity of the samples, 
as observed by the much higher absorbances of the liposomes. 
 
Research into the aggregation behaviour of azobenzene-containing lipid 
analogues in liposomes by Kuiper and Engberts suggests that the blue-shift 
observed to occur in the liposomes is as result of a degree of H-aggregation of 
the azobenzene compounds
9.  A π-π* absorption band appearing between 320 
and 350 nm may be attributed to the formation of clusters of azobenzene 
molecules within the bilayer
9
. 
 
The enzyme assay experiment - The enzyme assay experiment was first tested on 
DOPC liposomes without bis-Azo-PC in order to check the validity and 
 repeatability of the method.  Figure 2.11 shows a typical enzyme assay profile 
for DOPC liposomes containing DGK. 
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Figure 2.11. A plot showing a typical enzyme assay profile for DOPC liposomes 
containing DGK 
 
The experiment was repeated a number of times using DOPC-only liposomes in 
order to ensure repeatability of the method and reagents used.  The conditions for 
the experiments were as follows: 10 μL DGK stock solution at a concentration of 
0.739 μg μL-1 was refolded into 100 μL of DOPC liposomes.  20 μL of this 
sample was then diluted into 100 μL PIPES buffer.  The DGK/liposome solution 
was then added to a cuvette containing 250 μL of assay mix with 3 mM DBG 
and 10 μL linking enzymes and mixed thoroughly.  The enzyme assay 
measurements were then started.  The experiments were carried out at 20 °C.  
The results for the experiments are shown in Figure 2.12. 
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Figure 2.12. Plots for the enzyme assay analysis of two samples of DOPC 
liposomes containing DGK (samples 10 (black) and 11 (red)) 
 
Linear fitting analysis carried out on the plots gave slopes of -0.07036 AU for 
sample 10, and -0.07671 AU for sample 11, which shows a reasonably close 
correlation between the two experiments carried out under the same conditions.  
The specific enzyme activities for these samples are 0.415 μmol min-1 mg-1 for 
sample 10 and 0.452 μmol min-1 mg-1 for sample 11. 
 
The experiment was then repeated with DOPC liposomes containing 
azobenzenes 1 and 2.  In the presence of these azobenzenes, there was no change 
in the absorbance, indicating there was an inhibiting factor present.  It is possible 
that the azobenzene compounds, which terminate in a carboxylic acid group and 
a hydroxyl group respectively, were reacting with an active reagent of the assay 
mixture used in competition with the enzyme.  In addition, Balasubramanian et 
al. discovered that an enzyme assay carried out using α-chymotrypsin could be 
inhibited in the presence of an azobenzene carboxylic ester compound
3
. 
 
The experiment was then repeated using liposomes containing bis-Azo-PC.  The 
conditions for the experiment were as follows: 10 μL of DGK stock solution was 
refolded into 100 μL of bis-Azo-PC/DOPC liposomes.  10 μL of this sample was 
then diluted into 100 μL PIPES buffer.  The DGK/liposomes solution was then 
 added to a cuvette containing 250 μL of assay mix with 3 mM DBG and 10 μL 
linking enzymes and mixed thoroughly.  The enzyme assay measurements were 
then started.  The experiment was carried out at 20 °C.  The result for the 
experiment is shown in Figure 2.13. 
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Figure 2.13. Plot for the enzyme assay analysis of a sample of DOPC/bis-Azo-
PC liposomes containing DGK (sample 1) 
 
Linear fitting analysis carried out on the graph gave a slope of -0.1027 AU, and a 
specific activity of 0.605 μmol min-1 mg-1, which is significantly higher than the 
slopes obtained for DOPC-only liposomes previously.  This is not due to the 
presence of bis-Azo-PC, which is not expected to have an enhancing effect on 
the activity of the protein, but instead is probably due to the problems with 
repeatability of results encountered during this research. 
 
In order to test the effect of photoswitching of bis-Azo-PC in DOPC liposomes 
on the activity of the protein, the liposomes were irradiated at 350 nm for 15 
minutes in order to switch the azobenzene compound into the cis state.  The 
sample was then incubated with DGK for a further 15 minutes (10 μL of DGK 
stock solution refolded into 100 μL of the liposomes, followed by a further 
dilution of 20 μL of this sample into 100 μL PIPES buffer).  Following the 
incubation period, the reaction was initiated by adding the liposomes to the assay 
 mix.  The samples were kept in the dark to avoid back-conversion into the 
ground state (an equilibrium mixture of trans and cis states).  The experiment 
was repeated by photoswitching the samples into either the cis (350 nm) or trans 
(440 nm) states.   The results of the repeated experiments are shown in Figures 
2.14 and 2.15. 
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Figure 2.14. Plots for the enzyme assay analysis of samples of DOPC/bis-Azo-
PC liposomes containing DGK after photoswitching samples 2 (black), 4 (red) 
and 6 (blue) to the cis state 
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Figure 2.15. Plots for the enzyme assay analysis of samples of DOPC/bis-Azo-
PC liposomes containing DGK after photoswitching samples 3 (black), 5 (red) 
and 7 (blue) to the trans state 
 Linear fitting analysis was carried out on each graph to produce a slope and the 
specific activity of the protein.  These are shown in Table 2.2. 
 
Sample State Slope (AU) Specific Activity 
(μmol min-1 mg-1) 
2 Cis -0.1142 6.73 
3 Trans -0.0731 4.31 
4 Cis -0.0836 4.93 
5 Trans -0.0778 4.59 
6 Cis -0.0515 3.04 
7 Trans -0.0898 5.29 
  Standard 
Deviation 
1.21 
 
Table 2.2.  Table of specific activities for the enzyme assay of DOPC/bis-Azo-PC 
liposomes containing DGK 
 
From the calculated slopes and specific activities it can be seen that there is no 
reproducibility to these results; therefore they could not be used to give an 
indication of the effect of photoswitching the azobenzene on the activity of the 
protein. 
 
The experiment was repeated on DOPC liposomes to try to produce an accurate, 
repeatable method of analysing each sample with as little variation as possible.  
The conditions were as follows: 10 μL of DGK stock solution was refolded into 
100 μL of DOPC liposomes.  20 μL of this sample was diluted into 100 μL 
PIPES buffer.  The DGK/liposome solution was then added to a cuvette 
containing 250 μL of assay mix, with 3 mM DBG and 10 μL linking enzymes, 
and mixed thoroughly.  The enzyme assay measurement was then started.  The 
experiments were carried out at 20 °C.  The results for the experiments are 
shown in Figure 2.15. 
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Figure 2.15. Plots for the enzyme assay analysis of samples of DOPC liposomes 
containing DGK (samples 2 (black), 3 (red), 4 (blue), 5 (green), 6 (pink), 7 
(mustard) and 8 (dark blue)) 
 
Linear fitting analysis was carried out on each graph to produce a slope and 
specific activity.  These are shown in Table 2.3. 
 
Sample Slope (AU) Specific Activity 
(μmol min-1 mg-1) 
2 -0.0893 5.26 
3 -0.0548 3.23 
4 -0.0731 4.31 
5 -0.0675 3.98 
6 -0.0682 4.02 
7 -0.063 3.71 
8 -0.0607 3.58 
 Standard 
Deviation 
 0.65 
 
Table 2.3.  Table of specific activities for the enzyme assay of DOPC liposomes 
containing DGK 
 
 These results show the amount of variation between samples using the same 
conditions, reagents and methods.  At this point it was decided to discontinue this 
series of experiments due to the fact that, with such variation observed among 
identical samples, the difference between the slopes of the cis-state and trans-
state bis-Azo-PC/DOPC liposomes would be too small to be able to form any 
firm conclusions about the effect of photoswitching on the enzyme activity. 
 
Problems with the methodology – The results obtained for both the DOPC-only 
and the DOPC/bis-Azo-PC liposomes were not reproducible, which indicated 
that any experiments to switch the states of the azobenzene-containing compound 
between cis and trans in order to effect a change in the activity of the protein 
would not produce results with a sufficiently significant difference to be able to 
distinguish between the activities of the two states.  This is probably due to the 
fact that the inherent difference in activity between the two photo-states is too 
small to allow it to be observed using this method.   Proteins in vivo can tolerate 
a wide range of environmental conditions, including high pressures in the cell 
membrane (several hundreds of atm) and bilayer tension caused by curvature 
frustration
18
.  It is possible that the change induced in the bilayer by 
photoswitching between the cis and trans states is not significant enough to effect 
a change on the protein activity.   
 
The stability of the reagents may have been a factor in the variation in the 
experimental results, but this was partly alleviated by re-extruding the liposomes 
and using fresh protein, assay mix, and DBG stock for every set of experiments.  
In addition, the condition of the liposomes was visually checked to ensure that 
there was no degradation during the experiments.  The preparation of the DBG 
stock was complicated by the insolubility in water.  Care was taken to ensure that 
all of the DBG for each stock solution was at least suspended in PIPES buffer 
prior to the experiment; however it is possible that the compound could have 
dropped out of solution while the experiments were running, thereby reducing 
the concentration of this reagent. 
 
The azobenzene compound itself may have aggregated within the liposomes, 
which introduces another uncontrollable element to the experiments.  The 
 appearance of the π-π* absorption band at ~ 320 nm in the UV spectrum of 
DOPC/bis-Azo-PC liposomes has been attributed to a slight degree of H-
aggregation
9
.  The aggregation of the azobenzene compound may also contribute 
to the variation in the results. 
 
Any of the factors described may have contributed to the variation in results.  
The reagent stability was partly alleviated by re-extruding the liposomes and re-
synthesising the DBG stock for every set of experiments, but this introduces an 
unavoidable cost of time, and for DBG in particular, budget.  The issue of 
possible aggregation of azobenzene compounds in DOPC liposomes may be 
solved by reducing the concentration; but a large decrease in concentration may 
render it impossible to analyse the samples using UV/vis spectroscopy.  
 
Part 5. Conclusion 
 
UV/visible spectroscopy was used to analyse the spectra of three azobenzene-
containing compounds: azobenzene compounds 1 and 2, and bis-Azo-PC.  A 
sample of azobenzene 2 produced π-π* and n-π* transitions of 350 nm and 440 
nm, respectively, for the trans state isomers, and 345 nm and 440 nm for the cis 
state isomers.  A repeat of the experiments on a sample of azobenzene 1 showed 
that the sample failed to photoisomerise under the same conditions, possibly due 
to tautomerism
20
.  A sample of bis-Azo-PC produced π-π* and n-π* transitions of 
350 nm and 438 nm, respectively, for the trans isomers, and 343 nm and 440 nm 
for the cis state isomers.  The π-π* and n-π* transitions for these spectra are in 
agreement with those previously reported
17
. 
 
When incorporated into DOPC liposomes, the π-π* transition was found to have 
changed to 320 nm, while the n-π* transition was no longer visible.  
Photoisomerisation between the trans and cis states also produced two isosbestic 
points, while only one was observed for the azobenzene compounds in isolation.  
The blue-shift of the π-π* transition may be attributed to a degree of H-
aggregation of bis-Azo-PC in the DOPC bilayer
9
.   
 
 Enzyme assay experiments were then carried out on DOPC-only and 
DOPC/azobenzene liposomes.  The enzyme assay experiment was successfully 
carried out using DOPC-only liposomes, and then repeated using 
DOPC/azobenzene 1 and DOPC/azobenzene 2 liposomes.  The use of these 
azobenzene compounds inhibited the activity of the enzyme, possibly by 
competing for one of the reagents used in the assay.   
 
The enzyme assay experiment was then carried out on DOPC/bis-Azo-PC 
liposomes.  The azobenzene compound did not competitively inhibit the enzyme.  
However the investigation into the effect of azobenzene photoswitching on the 
enzyme activity could not be completed due to the fact that the subsequent 
change in activity was too small to be confidently attributed to influence on the 
protein by the change in bilayer properties.   
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 Chapter 3: Phase Behaviour 
  
Part 1. Introduction 
 
Analysis of Lipid Phase Behaviour - The phase behaviour of lipids in model 
membranes has been extensively researched in an effort to predict the behaviour 
of the lipid species which comprise the plasma membrane.  Issues of particular 
interest include the role of cholesterol and the formation of the lo phase, as well 
as the function of membrane lipid heterogeneity
1
.  Cell membranes are mimicked 
using a range of models, such as unilamellar and multilamellar vesicles of 
varying sizes, and lipid monolayers
1
.  A variety of experimental techniques has 
been used to analyse lipid properties and phase behaviour in model membranes, 
including differential scanning calorimetry (DSC)
2
, Fourier transform infrared 
spectroscopy (FTIR)
2
, atomic force microscopy (AFM), wide- and small-angle x-
ray scattering
3-5
, fluorescence microscopy
5-7
, fluorescence resonance energy 
transfer (FRET)
5, 8
, and NMR spectroscopy 
9
.   
 
DPPC is a commonly used component of phospholipid mixtures due to its 
relatively low melting point and tendency to form the lo phase in the presence of 
cholesterol or sphingomyelin.  The phase behaviour of this lipid in a range of 
mixtures has been extensively reported
7
.  Various methods have been used to 
produce phase diagrams of DPPC and deuterated DPPC bilayers containing 
varying amounts of cholesterol, including molecular acoustics techniques and 
DSC
10, 11
; x-ray diffraction
4
; and 
2
H-NMR
12, 13
.   
 
Serotonin Receptor Agonists – Serotonin (5-hydroxytryptamine, or 5-HT) 
(Figure 4.1) is a neurotransmitter with a variety of physiological roles, including 
the regulation of appetite, moods, sleeping patterns, and gastrointestinal 
function
14
. 
 
 
Figure 3.1. The structure of serotonin (5-hydroxytryptamine)
15 
 The 5-HT receptors are G-coupled protein receptors with the sub-types 5-HT1-7, 
with the exception of 5-HT3, which is a ligand-gated ion channel (LGIC)
16
.  
Serotonin receptor agonists include many classes of drugs, such as 
antidepressants, antipsychotics, appetite suppressants and psychoactives
17
.   
 
A study carried out by Lorch and Lopez analysed the locations and orientations 
of a range of 5-HT1A receptor ligands in DOPC/cholesterol bilayers using MAS-
NOESY NMR
18
.  The research analysed the agonists serotonin; LY-165,163; 
quipazine; 8-OH-DPAT; and buspirone.   The study was expanded as part of the 
PhD research, focusing on the phase behaviour of DPPC/cholesterol/agonist 
bilayers.   
 
 
 
Figure 3.2. Structures of the 5-HT1A agonists a) quipazine, and b) LY-165,135 
 
Quipazine (Figure 3.2a) and LY-165,163 (Figure 3.2b) were selected from the 
group of agonist compounds due to the fact that they did not produce NMR 
resonances in the cholesterol region (up to 2.3 ppm).  This allowed 
cholesterol/agonist cross-peaks to be observed when analysing d62-
DPPC/cholesterol/agonist bilayers using MAS-NOESY NMR. 
 
 
 Analysis of the Phase Behaviour of DPPC Samples Using 
2
H-NMR - The phase 
behaviour of deuterated DPPC (d62-DPPC) was analysed by Davis
19
.  The main 
gel-to-fluid lamellar phase transition occurs at a temperature of 310 K, which is 4 
K lower than the transition for protonated DPPC.   
 
The phase behaviour of d62-DPPC with varying concentrations of cholesterol (0 – 
25 mol%) was analysed by Vist and Davis
13
 and by Huang et al
12
.  A phase 
diagram was generated for cholesterol concentrations from 0 – 30 mol%.  At 20 
mol%, the concentration used in this research, there is evidence of a mixed lo + ld 
phase from 310 K to 316 K, followed by the fluid lamellar phase. 
 
Characteristics of 
2
H-NMR Spectra of Lipid Bilayers – Indications of phase 
behaviour in lipid bilayers such as DPPC/cholesterol samples can be obtained 
from the dePaked 
2
H-NMR spectra.  DPPC spectra in the gel phase have broad 
shoulders, no well-defined central plateau, and no detail to the peaks of the 
plateau.  As the temperature increases, and the sample enters the fluid lamellar 
phase, the edges of the plateau become sharp and well-defined, and the peaks in 
this region become resolvable.  Figure 3.3 gives an example of the progression of 
the 
2
H-NMR spectra from the gel phase through to the fluid lamellar phase for a 
sample of d62-DPPC
13
. 
 
 
 
Figure 3.3. 
2
H-NMR spectra of d62-DPPC  showing the change in spectral 
characteristics as temperature increases, analysed by Vist and Davis
13
 
 
  
 
Figure 3.4. 
2
H-NMR spectra of d62-DPPC with 15 mol% cholesterol showing the 
change in spectral characteristics as temperature increases, analysed by Vist 
and Davis
13
 
 
There is a noticeable difference between the spectra for d62-DPPC and those of 
d62-DPPC/cholesterol at a concentration of 15 mol% (Figure 3.4).  The gel phase 
spectra resemble those of d62-DPPC until a temperature of 303 K.  At this point, 
the shoulders of the spectrum become more sharply defined, which indicates a 
state of phase coexistence (gel + lo phase).  At 313 K the spectrum adopts the 
characteristics of the mixed ld + lo phase – sharply defined central peaks but 
rounded plateau edges.  The spectral characteristics at 318 K indicate that the 
 sample is in the fluid lamellar phase, with no further phase coexistence.  From 
this temperature onwards the spectra become narrower and increasingly well 
resolved due to increasing sample mobility
13
. 
 
Moments Analysis – Phase behaviour can be analysed using moments analysis, a 
technique used to determine both the distribution of quadrupolar splittings (ΔνQ) 
and the distribution of order parameters (SCD) in a 
2
H NMR spectrum.  Both of 
these distributions can indicate phases of lipid samples and show where phase 
transitions and phase coexistences occur.  The first moment, M1, is directly 
proportional to the average quadrupolar splitting (|ΔνQ|) and the average order 
parameter (|SCD|)
19-25
.   
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Equation 13  
 
The second moment, M2, is directly proportional to the squares of the average 
quadrupolar splitting (|ΔνQ
2
|) and the average order parameter (|SCD
2
|)
19-25
.   
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Equation 14 
 
The direct correlations between Mn, order parameter, and quadrupolar splitting, 
allows the moments to be used as a measure of increasing or decreasing order 
parameter and quadrupolar splitting.  For example, a decrease in average order 
parameter, which may result from a gel-to-fluid lamellar phase transition, 
produces a decrease in M1.  
 
 
  The first and second moments can then be used to generate the parameter Δ2, 
which is the relative mean square deviation (r.m.s.d.) of the distribution of 
quadrupolar splittings or order parameters
19-25
. 
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Equation 15 
 
Small values of Δ2 indicate small variations in the distribution of quadrupolar 
splittings, while a large Δ2 value indicates larger variations.  The highest value of 
Δ2 is found at the phase transition point
19-25
.  
 
Central Terminal Methyl Splitting – Central terminal methyl (CTM) splitting 
data provides an indication of the presence of the lo phase, coexisting with either 
the gel or ld phases.  It arises due to the inequivalence of the terminal methyl 
groups of the phospholipid sn1 and sn2 acyl chains due to the physical properties 
of the bilayer in the lo phase.  It is not observed to occur in either the pure gel or 
fluid lamellar phases
26, 27
. 
 
Part 2. Aims 
 
The aim of the experiment was to use 
1
H and 
2
H NMR spectroscopy to 
characterise the phase behaviour of liposomes containing DPPC, cholesterol and 
serotonin receptor agonists, which would then be further analysed using NOESY 
spectroscopy (as described in Chapter 4).   
 
Part 3. Experimental 
 
Materials – 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), chain-
deuterated 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (d62-DPPC) and 
cholesterol were purchased from Avanti Polar Lipids (Alabaster, AL).  All other 
chemicals including quipazine (Q) and LY-165, 135 (LY) were purchased from 
Sigma. 
 Sample Preparation – Samples of DPPC or DPPC-d62/cholesterol, DPPC or 
DPPC-d62/agonist, and DPPC or DPPC-d62/cholesterol/agonist were prepared at 
molar ratios of 8:2, 9:1 and 7:2:1 respectively.  The typical amount of DPPC 
used in each experiment was approx. 80 mg.  The lipids and agonist were co-
dissolved in chloroform/methanol (1:1 v/v).  The solvents were evaporated under 
vacuum, and the resulting lipid cake was suspended in 1 mL of doubly distilled 
water, frozen in liquid nitrogen, and then lyophilised overnight under high 
vacuum.  The dry lipid mixtures were hydrated with ~ 200 µL of D2O for proton 
NMR and H2O for deuterium NMR.  The mixtures were then transferred into 
4mm MAS rotors.   
 
NMR Measurements – All NMR experiments were carried out on a Bruker 
Avance II 500 MHz spectrometer using a 4mm MAS probe operating at a 
frequency of 500.1025 MHz (
1
H), and a wideline probe operating at a frequency 
of 76.773 MHz (
2
H).  Experiments were carried out at an MAS speed of 10 kHz 
(
1
H), while deuterium experiments were carried out without spinning.  
1
H NMR 
spectra were externally referenced to tetramethylsilane (TMS) at 0 ppm. 
   
1H experiments were conducted with a typical π/2 pulse length of 7 µs and a 
relaxation delay of 4 s.  Proton decoupling was achieved using TPPM (30 kHz).  
2
H experiments were conducted with a spectral width of 100 kHz, a recycle delay 
of 1 s, an echo delay of 30 μs, an acquisition time of 10 ms, 90° pulses of 5.5 μs, 
and between 2k and 4k scans.  Measurements were taken at 1 K intervals 
between 273 K and 333 K (as determined by the thermocouple).   
 
All of the NMR data were processed using TopSpin version 1.3 (Bruker 
Instruments, Karlsruhe, Germany).  
2
H spectra were de-Paked and the spectral 
moments were calculated using NMR Depaker software
28
.    
 
NMR experiments on the samples of d62-DPPC/LY and d62-
DPPC/cholesterol/LY were carried out by C. Windle of the University of Hull.  
The results are reproduced here with permission. 
 
 
 Part 4. Results and Discussion 
 
The assignments for the lipid, cholesterol and drug signals were allocated 
according to studies by Lopez and Lorch, Scheidt et al. and Soubias et al
18, 29, 30
.  
The DPPC proton assignments are shown in Table 3.1, in order of increasing 
chemical shift (ppm). 
 
Carbon number Resonance/ppm 
C16 0.9 
CH2 (n) 
The aliphatic lipid chain atoms 
~ 1.2 
C3 1.6 
C2 2.3 
γ, Gamma 3.3 
β, Beta 3.7 
G3  4.0 
Overlapped G1 and α, alpha resonances 4.35 
G2 5.3 
 
Table 3.1. DPPC Proton Resonances 
 
The serotonin-receptor agonists‟ resonances (Q and LY) were also numbered in 
order of increasing chemical shift (ppm).  These are shown in Tables 3.2 and 3.3. 
Carbon number Q resonance/ppm 
Q1 3.45 
Q2 7.17 
Q3 7.33 
Q4 7.47 
Q5 7.60 
Q6 7.75 
Q7 7.97 
 
Table 3.2. Q proton resonances 
 Carbon number LY resonance/ppm 
L1  2.8 
L2 6.7 
L3 7.0 
L4 7.4 
 
Table 3.3. LY proton resonances 
 
The cholesterol proton assignments are shown in Table 3.4, in order of increasing 
chemical shift (ppm). 
 
Carbon number Resonance/ppm 
C18
C 
0.8 
C26/27
C 
0.9 
C9/21/19
C 
1.05 
C14/17/24
C 
1.20 
C7/8/11/15/25
C 
1.50 
C4
C 
2.3 
 
Table 3.4. Cholesterol proton resonances 
 
The use of a chain-deuterated phospholipid eliminates signals in the aliphatic 
region of the spectrum (0 ppm to 1.6 ppm), thereby ensuring that the previously 
hidden cholesterol aliphatic and methyl signals become visible.  This enables the 
observation of cholesterol peaks which would otherwise be obscured by much 
more intense phospholipid peaks. 
 
Phase Behaviour - The phase behaviour of all six samples was determined using 
data obtained from moments analysis, order parameters, visual analysis of the 
spectra, differential scanning calorimetry (DSC), and central terminal methyl 
(CTM) splitting data. 
 
 Visual analysis - The 
2
H NMR spectra of d62-DPPC show characteristic gel phase 
spectra below the gel-to-fluid lamellar phase transition, as indicated by the lack 
of resolution (spectra at 308 K and 309 K, Figure 3.5).  The fluid lamellar phase 
then appears at 310 K, as shown by the appearance of narrow splitting and well-
resolved peaks.  The resolution of the peaks improves with the increase of 
temperature.   
 
 
 
Figure 3.5. 
2
H NMR spectra of d62-DPPC at temperatures ranging from 308 K to 
312 K at 1 K intervals, showing the gel-to-fluid lamellar phase transition.  The 
inset displays an expansion of the middle of 20 kHz of each spectrum 
 
The 
2
H NMR spectra of d62-DPPC/Q show the effect of Q on the d62-DPPC 
bilayer (Figure 3.6).  At 303 K the spectrum shows the emergence of shoulders 
and more resolved peaks which might indicate a separate phase between the gel 
and fluid lamellar phases, which is not evident from the M1 and Δ2 data.  This 
phase could be attributed to the ripple phase.  It is possible that the elongated 
transition phase may be attributed to the Pβ‟ phase; alternatively it could be an 
additional pre-transition phase.  The spectra also show that the fluid lamellar 
phase transition occurs between 303 K and 308 K, as all of the spectra from this 
temperature onwards are in the fluid lamellar phase.  This is corroborated by the 
data from the M1 and Δ2 results. 
 
  
 
Figure 3.6. 
2
H NMR spectra of d62-DPPC/Q at temperatures ranging from 303 K 
to 308 K at 1 K intervals, showing the gel-to-fluid lamellar phase transition.  The 
inset displays an expansion of the middle of 20 kHz of each spectrum 
 
The 
2
H NMR spectrum of the sample of d62-DPPC/cholesterol show gel phase 
spectra at 283 K.  At 293 K the appearance of prominent shoulders and evidence 
of splitting in the central terminal methyl peak suggests the emergence of a 
mixed [gel + lo] phase.  At 313 K, when the sample is expected to be in the [ld + 
lo] phase, the spectrum shows a wider distribution of splittings and an absence of 
central terminal methyl peak splitting, which indicates the presence of the fluid 
lamellar phase.  Above 323 K the resolution of the spectrum increases, indicating 
that the system is in the fluid lamellar phase.  These spectra are shown in Figure 
3.7. 
 
  
 
Figure 3.7. 
2
H NMR spectra of d62-DPPC/cholesterol at temperatures ranging 
from 283 K to 333 K at 10 K intervals.  The inset displays an expansion of the 
middle of 20 kHz of each spectrum 
 
The 
2
H NMR spectrum of the sample of d62-DPPC/cholesterol/Q shows gel 
phase spectra at 283 K, followed by the appearance of the [gel + lo] mixed phase 
at 293 K and 303 K.  At 313 K an increased resolution indicates the appearance 
of the [ld + lo] phase.  From 323 K onwards the spectra are in the fluid lamellar 
phase.  The spectra are shown in Figure 3.8. 
 
 
 
Figure 3.8. 
2
H NMR spectra of d62-DPPC/cholesterol/Q at temperatures ranging 
from 283 K to 333 K at 10 K intervals.  The inset displays an expansion of the 
middle of 20 kHz of each spectrum 
 The 
2
H NMR spectra of d62-DPPC/cholesterol/LY show the presence of gel 
phase characteristics at 283 K, followed by the emergence of shoulders at 293 K, 
which indicates the existence of lo-phase lipids (Figure 3.9).  This corresponds 
with the presence of the lo phase from 280 K to 325 K, as observed from the 
CTM splittings data. 
 
 
 
Figure 3.9. 
2
H NMR spectra of d62-DPPC/cholesterol/LY at temperatures 
ranging from 273 K to 333 K in 10 K intervals.  The inset displays an expansion 
of the middle of 20 kHz of each spectrum 
 
The 
2
H NMR spectra for the sample of d62-DPPC/LY show the effect of LY on 
the bilayer (Figure 3.10).  At 304 K and 305 K the spectrum shows the 
emergence of shoulders and more resolved peaks which might indicate a separate 
phase between the gel and fluid lamellar phases.  The spectra show that the fluid 
lamellar phase transition occurs between 304 K and 309 K. 
 
  
 
Figure 3.10. 
2
H NMR spectra of d62-DPPC/LY at temperatures ranging from 304 
K to 310 K at 1 K intervals, showing the gel-to-fluid lamellar phase transition.  
The inset displays an expansion of the middle of 20 kHz of each spectrum 
 
M1 data - M1 data obtained from deuterium NMR spectra of samples is shown in 
plots 3.1 (Q samples) and 3.2 (LY samples). 
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Plot 3.1 Comparison of M1 data for samples of d62-DPPC (black squares), d62-
DPPC/Q (blue triangles), d62-DPPC/cholesterol (red diamonds), and d62-
DPPC/cholesterol/Q (green triangles) 
 The main features of the plot of M1 for d62-DPPC are the regions: 273 K to 300 
K; 301 K to 309 K; and 310 K to 333 K.  From 273 K to 300 K, a shallow 
negative slope indicates that the sample is in the gel (Lβ) phase.  From 301 K to 
303 K the negative gradient of the slope increases sharply, followed by another 
negative slope from 303 K to 309 K.  The slope from 303 K to 309 K is 
attributed to the presence of another pre-fluid lamellar phase: the ripple (Pβ‟) 
phase, in which the lipid molecules are tilted at an angle to the bilayer normal 
axis
19, 31
.  The sharp decrease in gradient from 301 K to 303 K may be attributed 
to an additional sub-gel phase known as the tilted gel (Lβ‟) phase, which has been 
shown to occur at < 301 K; however, there is no further evidence from our 
studies to confidently assign this phase
31, 32
.  The Pβ‟ phase is then followed by 
the transition into the fluid lamellar (Lα) phase at 309/310 K.  This is shown by a 
steep drop in M1 over a short, 1 K interval.   
 
The M1 plot for the samples of d62-DPPC only and d62-DPPC/cholesterol match 
up well with those reported previously, although the M1 spectra reported for d62-
DPPC by Davis does not show the ripple phase as clearly as observed in Plot 
3.1
13, 19, 26
.  The smoothing effect observed on the addition of cholesterol also 
matches previous data
13
. 
 
The addition of cholesterol to the d62-DPPC bilayer produces some significant 
changes, most notably the disappearance of a steep gel-to-fluid lamellar phase 
transition.  The plot of M1 shows a smooth curve which may be divided into 
three separate gradients, possibly delineating three phases or areas of phase 
coexistence.  The areas of phase coexistence are found from 273 K to 
approximately 306 K; from approx. 306 K to approx. 318 K; and from approx. 
318 K to 333 K.  The phases were assigned according to previous phase 
diagrams of DPPC/20 mol% cholesterol, which gave the following phase areas: 
[gel + lo] phase coexistence from 303 K to 310 K; [ld + lo] phase coexistence 
from 310 K to 316 K; and fluid lamellar phase from 316 K onwards
13
.  The 
phases from the d62-DPPC/cholesterol sample were therefore assigned as [gel + 
lo] phase coexistence, 273 K to approx. 306 K; [ld + lo] phase coexistence from 
approx. 306 K to approx. 318 K; fluid lamellar phase from approx. 318 K to 333 
K.  The difference in transition temperatures may be due to the differences 
 between deuterated and protonated samples or due to the differences between 
methods of data analysis.  From the M1 plot it is not possible to determine the 
temperature at which the [gel + lo] phase coexistence begins.  The most important 
point to note is that the plot for this sample is dramatically different from the 
plots for d62-DPPC and d62-DPPC/Q, with regards to the steep gel-to-fluid 
lamellar phase transition observed for these samples.  The addition of cholesterol 
leads to the phenomenon of phase coexistence, which removes the gel-to-fluid 
lamellar phase transition.  Another important point to note is that M1 is lower in 
the gel/[gel + lo] phase than the values for the d62-DPPC and d62-DPPC/Q 
samples in this region, but highest overall in the fluid lamellar/[ld + lo] phase.   
 
The effect of cholesterol on a phospholipid bilayer has long been known to 
induce the appearance of the lo phase, which has characteristics halfway between 
those of the gel phase and the ld/fluid lamellar phase.  Previous research has 
observed that the presence of cholesterol in liposomes of varying composition 
has removed the sharp gel-to-fluid phase transition, as seen in Plot 3.1
13
. 
 
The addition of Q also results in some significant changes to the phase transition 
profile of d62-DPPC.  For the plot of M1 for d62-DPPC/Q the main features are: 
273 K to 303 K; 303 K to 307 K; and 307 K to 333 K.  From 273 K to 303 K a 
shallow negative slope indicates that the sample is in the gel phase, which 
mirrors the phase transition profile of d62-DPPC.  Over the interval of 303 K to 
307 K the sample undergoes a phase transition from the gel phase to the fluid 
lamellar phase, where it remains up to 333 K.  There are several important points 
to note in comparison to the phase transition profile of d62-DPPC alone.  The first 
is that there is no evidence of the existence of the ripple phase, which is observed 
to occur in d62-DPPC from 303 K to 309 K.  The second is that the value of M1 is 
decreased in comparison to d62-DPPC at the sub-fluid lamellar temperatures 
(from 273 K to 307 K).  The values become similar in the fluid lamellar phase.  
The third important point to note is that the gel-to-fluid lamellar phase transition 
takes place over a wider temperature interval than for d62-DPPC alone.  In 
addition, the phase transition is complete at a lower temperature (307 K) for this 
sample than for d62-DPPC (310 K).  In the case of d62-DPPC/Q it takes place 
over a range of 3 K, compared to 1 K for d62-DPPC.  From these three points it 
 can be theorised that the presence of Q has a disruptive effect on the d62-DPPC 
bilayer.  The relatively low value of M1 in the sub-fluid lamellar phases indicates 
that the bilayer has a lower distribution of both order parameters and quadrupolar 
splittings in this region than d62-DPPC alone, which reflects greater disorder and 
fluidity.  The presence of Q therefore has the effect of disrupting the rigidity of a 
gel-phase d62-DPPC bilayer, possibly by intercalating with the phospholipid 
molecules.  This also explains the lowering of the gel-to-fluid lamellar phase 
transition.  The apparent disappearance of the ripple phase from the spectra of 
samples containing Q may be due to the presence of Q molecules in the bilayer 
preventing the lipids from adopting a tilted conformation. 
 
The plot of M1 for d62-DPPC/cholesterol/Q has a very different profile to those of 
the other samples.  The main regions of interest are: 273 K to 278 K; 278 K to 
288 K; 288 K to 298 K; 298 K to approx. 312 K; and approx. 312 K to 333 K.  
The assignment of phases relies on the assignments previously made for d62-
DPPC/Q and d62-DPPC/cholesterol.  The assignments obtained for d62-
DPPC/cholesterol showed that there is an undefined mixture of the gel and [gel + 
lo] phases until approx. 310 K, followed by the appearance of the [ld + lo] phase 
coexistence from 310 K until 316 K, and the fluid lamellar phase from this 
temperature onwards.  The d62-DPPC/Q data showed that the presence of Q 
lowered the gel-to-fluid lamellar phase transition temperature by approx. 3 K.  
These data indicate that the region from 298 K to 312 K may by attributed to the 
[ld + lo] mixed phase, followed by the fluid lamellar phase from 312 K onwards.  
Although the phases from 298 K onwards may be fairly confidently assigned, the 
phase behaviour of the sample below this temperature requires the addition of 
more data from different methods due to the unexpectedly low M1 values present 
in these regions. 
 
In comparison to the M1 plot of d62-DPPC/cholesterol, it is clear that the addition 
of Q once again has a significant effect on the phase behaviour of the sample.  
The plots differ significantly from 273 K to 287 K with the appearance of the 
region of relatively low M1 values, and also differ in the region from 300 K to 
305 K, with the disappearance of the „hump‟ observed in the d62-
DPPC/cholesterol spectrum.  Overall the M1 values are lower in the presence of 
 Q.  Although the region from 273 K to 287 K could be assigned to an additional 
sub-gel phase, this is counter-intuitive to the high M1 values (and hence high 
order parameters) expected at these low temperatures.  It has also not been 
observed to occur in any other system.  The regions of the spectrum are assigned 
as: 273 K to 287 K, gel phase; 287 K to 298 K, [gel + lo] phase; 298 K to approx. 
310 K, [ld + lo] phase; and from approx. 310 K onwards, fluid lamellar phase. 
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Plot 3.2 Comparison of M1 data for samples of d62-DPPC (black squares), d62-
DPPC/LY (blue triangles), d62-DPPC/cholesterol (red stars), and d62-
DPPC/cholesterol/LY (green triangles) 
 
The main features of the plot of M1 for d62-DPPC/LY are: 273 K to 303 K; 303 K 
to 309 K; and 309 K to 333 K.  From 273 K to 303 K a shallow negative slope 
indicates that the sample is in the gel phase.  Over the interval of 303 K to 309 K 
the sample undergoes a phase transition from the gel phase to the fluid lamellar 
phase, where it remains up to 333 K. 
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Plot 3.3 Comparison of M1 data for samples of d62-DPPC/Q (black squares) and 
d62-DPPC/LY (red diamonds) 
 
A comparison of the M1 plots for d62-DPPC/Q and d62-DPPC/LY shows very 
little difference between the data; the only difference occurs during the gel-to-
fluid lamellar phase transition, which takes place over a slightly longer 
temperature interval for LY than for Q (303 K to 309 K, rather than to 307 K).  
This result indicates that the presence of LY has a similar effect to the presence 
of Q on the bilayer; both drugs disrupt the bilayer and lower the gel-to-fluid 
lamellar phase transition temperature. 
 
The main features of the plot of M1 for d62-DPPC/cholesterol/LY are: 273 K to 
292 K; 293 K to 305 K; and 306 K to 333 K.  As for the previous plots of d62-
DPPC/cholesterol and d62-DPPC/cholesterol/Q, it is divided up into three 
approximate areas with different gradients.  The region from 293 K to 305 K is 
assigned to the [ld + lo] mixed phase, with the fluid lamellar phase from 306 K to 
333 K.  The [gel + lo] phase may also be assigned to the region from 273 K to 
293 K, although it is not possible to tell from this data where the gel phase 
coexistence with lo-phase begins. 
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Plot 3.4 Comparison of M1 data for samples of d62-DPPC/cholesterol/Q (black 
squares) and d62-DPPC/cholesterol/LY (red circles) 
 
The main difference between the plots for d62-DPPC/cholesterol/Q and for d62-
DPPC/cholesterol/LY is the absence of the problematic region of low M1 values 
in a region normally associated with high M1 values (correlating to high order 
and parameter and quadrupolar splittings distributions), although the plot does 
show an increase in M1 from lower to higher temperatures before peaking.  Since 
high order parameters and large splittings are expected for lower temperatures, 
producing high M1 values, it is possible that an experimental error has resulted in 
low M1 values at low temperatures.    
 
 
 
 
 
 
 
 
 
 
 Δ2 data - Δ2 data obtained from deuterium NMR spectra of samples is shown in 
plots 3.5 (Q samples) and 3.6 (LY samples). 
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Plot 3.5 Comparison of Δ2 data for samples of d62-DPPC (black squares), d62-
DPPC/Q (red circles), d62-DPPC/cholesterol (blue triangles), and d62-
DPPC/cholesterol/Q (green triangles) 
 
The main features of the plot of Δ2 for the sample of d62-DPPC are: a negative 
slope from 273 K to 302 K; a positive slope followed by a peak maximum at 309 
K; and a steep drop from 309 K to 310 K, followed by a negative slope until 333 
K.  The maximum coincides with the gel-to-fluid lamellar phase transition 
temperature at 309 K, as shown in the M1 data.  The data shows three clear 
phases: gel phase from 273 K to 302 K; Pβ‟ phase from 303 K to 309 K; and 
finally the fluid lamellar phase from 310 K to 333 K.  This correlates with the 
phase transitions assigned from the M1 plot for this sample. 
 
The plot of Δ2 for the sample of d62-DPPC/Q comprises: a flat region extending 
from 273 K to 305 K; a peak maximum occurring at 305 K, which drops to a 
minimum at 307 K; and a flat region from 307 K to 333 K.  Δ2 is at a maximum 
at the point of phase coexistence (305 K).  The Δ2 profile resembles that of the 
d62-DPPC system, although it is less clear. 
 
 In the Δ2 plot of the sample of d62-DPPC/cholesterol there is no characteristic 
peak maximum followed by a trough as observed with the Δ2 plot of d62-DPPC.  
The lowest point of the plot occurs at approx. 308 K, and from that point the 
slope increases positively until 315 K then takes the form of a plateau until 333 
K.  Phase transition data obtained from the plot of M1 for this sample showed 
that the sample was in the fluid lamellar phase from approx. 316 K.  The area of 
low Δ2 plus a positive gradient, from 306 K to 315 K, corresponds to the region 
of [ld + lo] phase coexistence.  The onset of the fluid lamellar phase corresponds 
with the appearance of the second plateau.  Although this plot is not as clear, it is 
possible to see the same pattern as observed for the sample of d62-DPPC; the plot 
goes through a minimum point (at approx. 308 K) before rising to a higher point 
(at 315 K) and levelling off.  The lack of the peak maximum (observed to occur 
at 309 K for d62-DPPC and immediately followed by a steep drop to a minimum 
point) may reflect the lack of a clear phase transition from the [ld + lo] phase 
coexistence to the fluid lamellar phase, which is also observed in the M1 plot. 
 
The plot of Δ2 for the sample of d62-DPPC/cholesterol/Q does not appear to 
produce much useful information on the phase behaviour of the mixture.  The 
only significant feature of the plot is a minimum at 304 K, which coincides with 
the middle of the temperature range at which the [ld + lo] phase is observed to 
occur in the M1 plot (298 K to 312 K).  It is not possible to derive any 
information from any other part of the plot. 
 
The general shapes and features of the Δ2 plot obtained for the sample of d62-
DPPC agrees with previously published plots, although there is less variation 
between the values at different temperatures
19.  The general shape of the Δ2 plot 
of d62-DPPC/cholesterol also matches a previously published plot by Davis et al., 
although the concentration of cholesterol is higher (25 % vs. 20 %)
32
. 
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Plot 3.6 Comparison of Δ2 data for samples of d62-DPPC (black squares), d62-
DPPC/LY (blue triangles), d62-DPPC/cholesterol (red stars), and d62-
DPPC/cholesterol/LY (green triangles) 
 
The plot of Δ2 for the sample of d62-DPPC/LY shows some similarities to that of 
the d62-DPPC/Q, but is much clearer.  The main features are a peak maximum at 
298 K, followed by a negative slope leading to a point (at 305 K) followed 
immediately by a steep drop to a minimum point (308 K).  The steep drop takes 
place over an interval of 3 K.   
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Plot 3.7 Comparison of Δ2 data for samples of d62-DPPC/Q (black squares) and 
d62-DPPC/LY (red circles) 
 
Analysis of the M1 data showed that the gel-to-fluid lamellar phase transition 
took place from 303 K to 309 K, followed by the fluid lamellar phase from 309 
K onwards.  The results found for Δ2 (305 K to 308 K) follow these results 
closely.  However the maximum point at 298 K occurs when the sample is in the 
gel phase, which may indicate the presence of a sub-gel phase previously unseen 
in the M1 data. 
 
The plot of Δ2 for the sample of d62-DPPC/cholesterol/LY closely resembles that 
of the plot for d62-DPPC/cholesterol/Q, and also gives no clear information about 
the phase behaviour of the sample.  However it does succeed in showing that the 
plot obtained for the sample of d62-DPPC/cholesterol/Q was not an anomaly, and 
that both mixtures containing d62-DPPC, cholesterol, and drug have the same 
effect on the calculation and subsequent plotting of Δ2 values.   
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Plot 3.8 Comparison of Δ2 data for samples of d62-DPPC/cholesterol/Q (black 
squares) and d62-DPPC/cholesterol/LY (red stars) 
 
Central terminal methyl splitting data - Central terminal methyl (CTM) splitting 
data for the samples containing cholesterol is shown in Plot 3.9 in comparison 
with the corresponding M1 data.   
 
  
 
Plot 3.9 Central terminal methyl splitting data (right-hand axis, closed symbols) 
and M1 data (left-hand axis, open symbols  for samples of d62-
DPPC/cholesterol/Q (A), d62-DPPC/cholesterol/LY (B), and d62-
DPPC/cholesterol (C).  The phase transition boundaries are also denoted for lo 
(between the dotted lines) and gel/ld (between the dashed lines) 
 
The central terminal methyl (CTM) splitting peak data for the sample of d62-
DPPC/cholesterol shows that the splitting appears at a temperature of 293 K and 
disappears at a temperature of 317 K, which indicates that the lo phase emerges at 
293 K (and possibly lower, as it becomes more difficult to analyse the data for 
 splittings as temperature and resolution decrease), and that the sample is in the 
fluid lamellar phase from 317 K onwards.  This correlates closely to the phase 
transition temperatures obtained from the M1 data, which found that the sample 
was in the fluid lamellar phase from 318 K onwards.  It also provides a 
temperature for the emergence of the mixed [gel + lo] at 293 K, which was not 
obtained from the M1 data. 
 
The CTM splitting peak data for the sample of d62-DPPC/cholesterol/Q shows 
that the splitting appears at a temperature of 287 K and disappears at a 
temperature of 313 K.  Interestingly 287 K, the temperature at the start of the [gel 
+ lo] phase coexistence, is also the temperature at which the region of low M1 
transitions into the next region of higher M1 (plot 3.9).  This indicates that the 
low-M1 region may be attributed to the gel phase.  The end temperature of 313 K 
also correlates closely with the start of the fluid lamellar phase indicated by the 
M1 results (312 K).  This temperature is lower than the start of the fluid lamellar 
phase found for the sample of d62-DPPC/cholesterol (318 K), which agrees with 
the theory that the presence of Q lowers the temperature of the start of the fluid 
lamellar phase. 
 
The CTM splitting peak data for the sample of d62-DPPC/cholesterol/LY shows 
that splitting appears at a temperature of 280 K and disappears at a temperature 
of 327 K, which indicates a much wider lo phase range than observed for the 
sample containing Q.   
 
 
 
 
 
 
 
 
 
 
 Order parameter data - Order parameter data for all samples is shown in Plot 
3.10. 
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Plot 3.10 Comparison of order parameter data for samples of d62-DPPC (black 
squares), d62-DPPC/Q (red diamonds), d62-DPPC/cholesterol (blue triangles), 
d62-DPPC/cholesterol/Q (green triangles), d62-DPPC/LY (pink triangles), and 
d62-DPPC/cholesterol/LY (mustard triangles), all at 323 K 
 
The order parameter profile for the sample of d62-DPPC shows the profile 
expected of a lipid in the fluid lamellar phase.  The lowest order is found at the 
end of the sn-1 chain, C16.  Order parameter then increases towards the centre of 
the chain, reaching a maximum value at C8, before levelling off between C8 and 
C2.  The order parameter profile for the sample of d62-DPPC/Q is almost 
identical to that of d62-DPPC, indicating that in the fluid lamellar phase, the 
presence of Q does not have much of an effect on the dynamics of the bilayer. 
 
The order parameter profiles for the samples of d62-DPPC/cholesterol and d62-
DPPC/cholesterol/Q are also almost identical, confirming that the presence of Q 
does not have much of an effect when the samples are in the fluid lamellar phase.  
The order parameter profiles for the cholesterol-containing samples display 
increased order parameter values relative to the samples without cholesterol, 
which is due to the increased rigidity of lipid bilayers containing intercalated 
 cholesterol molecules.  The order parameter profile for the sample of d62-
DPPC/LY is almost identical to its Q-containing counterpart.  The profile for the 
sample of d62-DPPC/cholesterol/LY is more notable in that it displays the highest 
order overall, indicating that the presence of LY together with cholesterol has a 
significant effect on the order of the bilayer. 
 
DSC data - The DSC scan for the sample of d62-DPPC has two significant peaks, 
one at 304.3 K and one at 311.8 K (Figure 3.11).  These correspond to the onset 
of the ripple phase, at 303 K, and the fluid lamellar phase, at 310 K, as calculated 
from the M1 and Δ2 data.   
 
 
 
Figure 3.11. DSC scan of a sample of d62-DPPC, showing the ripple phase 
(304.4 K) and fluid lamellar phase (310 K) peaks 
 
The scan for the sample of d62-DPPC + Q shows a significant difference from 
that of the sample of d62-DPPC.  The two separate peaks denoting the ripple and 
fluid lamellar phase transitions are replaced by a single elongated peak at 307.6 
K, with an onset of 302 K.  This peak corresponds to the start of the elongated 
transition phase at 303 K, and the start of the fluid lamellar phase at 307 K.  The 
difference between the scans of d62-DPPC and d62-DPPC + Q indicates that the 
ripple phase does not appear in the Q-containing sample.  The scan is shown in 
Figure 3.12. 
  
 
Figure 3.12. DSC scan of a sample of d62-DPPC/Q, showing a wide peak at 
307.6 K with an onset of 302 K 
.  
The scan for the sample of d62-DPPC + Chol also shows a single peak, with an 
onset of 306.3 K, corresponding to the start of the [ld + lo] phase; a peak centre at 
310.6 K, corresponding to the centre of the [ld + lo] phase; and the end of the 
peak at approx. 320 K, which corresponds to the end of the [ld + lo] and the 
beginning of the fluid lamellar phase.  The scan for this sample is shown in 
Figure 3.13. 
 
 
 
Figure 3.13. DSC scan of a sample of d62-DPPC/cholesterol, showing a wide 
peak at 310.6 K with an onset of 306.3 K 
 The scan for the sample of d62-DPPC + LY shows a single peak with an onset of 
305.2 K and a peak centre at 308.9 K (Figure 3.14).  These temperatures 
correspond to the start of the elongated transition phase (303 K), and the start of 
the fluid lamellar phase at 309 K.   
 
 
 
Figure 3.14. DSC scan of a sample of d62-DPPC/LY, showing a peak at 308.9 K 
with an onset of 305.32 K 
 
Part 5. Conclusion 
 
The data obtained for the sample of d62-DPPC indicates that it is in the gel phase 
until 303 K.  From 303 K to 309 K it is believed to be in the ripple phase, and 
from 310 K onwards it adopts the fluid lamellar phase.  The phase transition 
temperatures are consistent for all datasets, with minor variations found in the 
case of Δ2, which may be due to the difficulty of visually analysing the data.  The 
order parameter data is consistent with the assumption that the sample should be 
in the fluid lamellar phase at 323 K.  Visual analysis of the spectra also agrees 
with the results, with the gel phase observed up to a temperature of 298 K, 
followed by the ripple phase from 303 K to 308 K, and the fluid lamellar phase 
from 313 K onwards.  Previously reported phase diagrams for DPPC give a 
ripple phase-to-fluid lamellar phase transition temperature of 315 K; ripple phase 
from 306 K to 315 K; and the gel phase below 306 K, in the case of protonated 
DPPC, and temperatures of 313 K for the start of the fluid lamellar phase, 301 K 
 for the start of the ripple phase, and gel phase below 301 K for deuterated 
samples
4, 12, 19
.   
 
The addition of 20 mol% cholesterol is expected to induce the formation of the 
liquid-ordered phase, and this is supported by the data generated for the sample 
of d62-DPPC/cholesterol.  The M1 data showed three gradual phase transitions, 
assigned to the [gel + lo] phase (273 K to 306 K), [lo + ld] phase (306 K to 318 
K), and fluid lamellar phase (318 K to 333 K).  These transition temperatures are 
only approximate due to the lack of clear-cut phase transitions in the presence of 
cholesterol.  The Δ2 data also shows evidence of possible phases, although it is 
not as clear to see as for the sample of d62-DPPC.   
 
Although the M1 and Δ2 data cannot be used to ascertain the start of the [gel + lo] 
phase, the CTM splitting data gives a temperature of 293 K for the start of this 
phase, ending at 317 K.  Since the temperature of the start of the fluid lamellar 
phase is so similar to the temperature found using the M1 data (318 K), it can be 
assumed that this is a good estimate of the start of the [gel + lo] phase.  However, 
since the resolution of the CTM splitting decreases with temperature, it may be 
possible that the start temperature of this phase is lower than stated.  Visual 
analysis of the spectra shows the emergence of shoulders characteristic of the 
mixed [gel + lo] phase at 288 K, and indicated that the fluid lamellar phase starts 
at 318 K.  The DSC results cannot be used to clarify the start temperature of the 
[gel + lo] phase, as the peak only shows the start of the [ld + lo] and fluid lamellar 
phases.  The exact transition temperatures of the phases in this sample may be 
clarified in further work by using additional techniques such as X-ray scattering, 
which measures bilayer thickness, to provide further evidence. 
 
The addition of Q to the d62-DPPC bilayer has more of a profound effect than 
expected.  The M1 data shows that the presence of Q both elongates the gel-to-
fluid lamellar phase transition and lowers the start temperature of this transition, 
as well as removing the ripple phase.  The gel-to-fluid lamellar phase transition 
begins at a temperature approx. 6 K lower than that of d62-DPPC‟s ripple phase-
to-fluid lamellar phase transition (303 K versus 309 K), and takes place over a 
range of 4 K (instead of over 1 K).  There is also no evidence of the formation of 
 an lo phase, which might be induced by the phase separation of the Q molecules.  
The Δ2 data is very unclear, but a pattern can be discerned which follows the 
characteristic plot of trough-peak-trough.  The order parameter data for this 
sample, and for the sample containing LY, shows that the addition of agonist 
does not have much of an effect on the profile of d62-DPPC only, indicating that 
the overall order parameter in the fluid lamellar phase does not change 
significantly in the presence of agonist.  Data derived from visual analysis and 
DSC confirm the gel-to-fluid lamellar phase transition temperatures as described. 
 
The addition of LY to the bilayer also has a significant effect on the phase 
behaviour.  The M1 data shows that the gel-to-fluid lamellar phase transition 
starts at 303 K (the same temperature as Q), but takes place over a range of 6 K.  
Interestingly, further research carried out by Windle, Buchoux and Lorch 
(unpublished data) suggests lo-phase formation at a temperature of 306 K in this 
sample, as shown by CTM splitting data.  This may suggest phase separation of 
the LY molecules, possibly due to the relative locations and orientations of these 
molecules (as discussed in Chapter 4).  The widened gel-to-fluid lamellar phase 
transition, from 303 K to 309 K, may be mirrored by the main features of the Δ2 
data, which show a negative slope from 305 K to 308 K.   
 
For both agonists, the addition of cholesterol mirrors the typical profile for a 
sample of DPPC/cholesterol at higher temperatures, but departs from this 
behaviour at lower temperatures.  In the case of the M1 data, both agonists 
display an increase in M1 before the start of lo phase onset (which occurs at 287 
K for Q and 280 K for LY, according to CTM splitting data).  The region of low 
M1 for Q lasts from 273 K to 277 K; from 277 K to 278 K there is significant 
increase in the value of M1, which corresponds exactly to the start of the mixed 
[gel + lo] phase.  The change in M1 for LY is less dramatic but still significant.  It 
is possible that there is an additional sub-gel phase which accounts for the region 
of low M1 at these low temperatures, although lipid phases at these temperatures 
are expected to produce higher M1 values due to increased order.  The results 
from the CTM splittings data show a significant increase in the temperature 
range of the lo phase for LY in comparison to Q; the range has expanded from 
286 K to 310 K (Q), to 280 K to 325 K (LY).  This suggests that LY has a much 
 greater effect on the bilayer than Q, possibly due to its orientation in the bilayer.  
The order parameter data shows a much higher order overall for the sample of 
d62-DPPC/cholesterol/LY than for any of the other samples; the sample is 
expected to be in a mixed lo phase at 323 K, which accounts for the increased 
order. 
 
In conclusion, the addition of agonists to d62-DPPC bilayers with and without 
cholesterol has marked effects on the physical properties of the bilayer.  The 
addition of Q, a relatively small molecule which orients parallel to the bilayer 
normal, thereby minimising disruption, shifts the start of the gel-to-fluid lamellar 
phase transition lower by 6 K, widens the temperature range over which the 
transition takes place, and removes evidence of the pre-transition ripple phase.  
The addition of a larger agonist molecule, LY, which orients perpendicular to the 
bilayer, also lowers the phase transition temperature and widens it by a greater 
amount.  LY also removes the ripple phase and possibly induces the presence of 
the lo phase in the absence of cholesterol.  In the presence of cholesterol, 
unidentified sub-gel phases are observed at low temperatures.  The sample of 
cholesterol with LY also has a much larger lo phase range when compared to 
samples containing cholesterol alone and cholesterol with Q.  These results show 
that the addition of molecules such as agonists or other drugs may have 
significant, unpredictable effects on a lipid bilayer. 
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 Chapter 4: Analysis of Drug Localisation and Orientation in a Model 
Membrane by NMR Spectroscopic Methods 
  
Part 1. Introduction 
 
The interactions of a foreign molecule, such as ethanol or pharmacological drugs, 
with the cell membrane depend on their molecular structures and chemical 
properties.  The interactions with the membrane vary; some drugs interact with 
protein receptors on the surface of the cell, initiating a cascade of events within 
the cell‟s interior such as enzyme activation, enzyme inhibition, or protein 
synthesis; some diffuse through the cell membrane in order to interact directly 
with biological macromolecules inside the cell; and some interact with the cell 
membrane itself, altering properties such as membrane composition and 
curvature
1
.  Drug design and synthesis is a costly and time-intensive process, but 
it may be partly facilitated by studying the effects of existing drugs on the 
membrane.  The interactions of a variety of drugs with the cell membrane have 
been studied; a comprehensive list of such studies has been compiled by Lucio et 
al
1
. 
 
A variety of methods have been used to investigate the drug/membrane 
interaction, including water/octanol partitioning, fluorescence experiments, DSC 
and X-ray scattering
1
.  However the technique of most relevance to this research 
is NMR spectroscopy; in particular, solid-state NMR, which is well-suited to the 
analysis of model membranes 
1
. 
 
Kuroda et al. used deuterium NMR to analyse the orientations and locations of 
the anaesthetic drugs benzocaine and butamben, using lipid suspensions of mixed 
compositions, and discovered that the locations of the drugs changed in the 
presence of cholesterol
2
.  Gaede and Gawrisch used pulsed field gradient (PFG) 
MAS-NMR to investigate the diffusion rate of ibuprofen in unilamellar 
liposomes
3
.  A variety of studies have used the technique of generating cross-
relaxation rates from NOESY experiments to indicate the probability of contact 
between lipid and drug molecules, thereby showing the location and orientation 
of drug molecules relative to the lipid bilayer.  Cross-relaxation rate experiments 
 have been used to determine the locations and orientations of ethanol, flavonoids, 
tryptophan, multi-drug transporter substrate molecules (including antibiotics such 
as ampicillin and penicillin G), and serotonin receptor agonist drugs
4-9
.   Holte 
and Gawrisch showed that ethanol locates in the interfacial region of the bilayer
4
, 
which was also found to occur for various flavonoid molecules
6
 and tryptophan
7
.  
The interfacial region was also found to interact strongly with the aromatic 
moieties of various multi-drug transporter substrates
8
.  Scheidt and Huster 
carried out a comprehensive review of the research into the interactions of 
various small-molecule species with phospholipid bilayers using NOESY cross-
relaxation rates, which also includes interactions between peptides and 
fluorescent dyes with the bilayer
10
.  The studies carried out showed that the 
various compounds analysed tended to locate mostly in the interface region of 
the bilayer due to their chemical properties.  The interfacial region allows contact 
with both the apolar (the top of the acyl chains) and polar (the charged 
headgroup) regions, and allows the formation of hydrogen bonds due to the 
presence of the carbonyl oxygen atoms in the glycerol group.  This allows a 
variety of compounds with different chemical compositions to adopt positions in 
this part of the bilayer. 
 
Eisensamer et al. found that the serotonin receptor protein co-localised with 
certain serotonin receptor agonist drugs in low buoyant density (LBD) fractions 
of cell membranes
11
.  This is the fraction closely associated with cholesterol-
enriched lipid domains, thus implying that both the serotonin receptor protein 
and their agonist drugs are co-localised within lipid domains.  It has been 
suggested that the co-localisation of receptor proteins with agonist drugs may 
facilitate or enhance signal transduction by decreasing the distance between drug 
and receptor, and increasing the probability of the drug coming into contact with  
the membrane-based receptor protein
12
. 
 
The study carried out by Lorch and Lopez used MAS NOESY cross-relaxation 
rates and induced chemical shifts to analyse the locations of serotonin-receptor 
agonist drugs in relation to a DOPC or brain lipids bilayer, where the brain lipids 
contained various phospholipids together with cholesterol
9
.  Induced chemical 
shift data showed that the serotonin-receptor agonist drugs interacted with 
 cholesterol more strongly than with phospholipids, which agrees with the 
hypothesis that certain drugs co-localise together with their receptors inside 
cholesterol-enriched lipid domains
9
.  
 
Part 2. Aims 
 
The aim of this research is to expand on the results found by Lorch and Lopez
9
 
for  the serotonin-agonist receptor drugs, quipazine (Q) and LY-163,165 (LY), 
using three-component model membranes containing a chain-deuterated 
phospholipid, cholesterol, and drug, and provide further evidence for the 
hypothesis that certain drugs co-localise with their receptor proteins in 
cholesterol-enriched lipid domains.  The use of chain-deuterated phospholipids 
enables the appearance and analysis of drug-cholesterol cross-peaks in the 
NOESY spectrum, which would otherwise be masked by the aliphatic 
phospholipid resonances. 
 
Part 3. Experimental 
 
Materials – 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), chain-
deuterated 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (d62-DPPC) and 
cholesterol were purchased from Avanti Polar Lipids (Alabaster, AL).  All other 
chemicals including Q and LY were purchased from Sigma. 
 
Sample Preparation – Samples of DPPC or DPPC-d62/cholesterol, DPPC or 
DPPC-d62/agonist, and DPPC or DPPC-d62/cholesterol/agonist were prepared at 
molar ratios of 8:2, 9:1 and 7:2:1, respectively, as described in Chapter 3.  
 
NMR Measurements – All NMR experiments were carried out on a Bruker 
Avance II 500 MHz spectrometer using a 4 mm MAS probe operating at a 
frequency of 500.1025 MHz (
1
H) Experiments were carried out at an MAS speed 
of 10 kHz (
1
H).  
1
H NMR spectra were externally referenced to tetramethylsilane 
(TMS) at 0 ppm. 
   
 1
H experiments were conducted with a typical π/2 pulse length of 7 µs and a 
relaxation delay of 4 s.  2D NOESY experiments had 256 or 512 increments and 
up to 64 scans per increment, with mixing times between 10 ms and 1000 ms.  
Experiments were conducted at 298 K, 308 K and 316 K (temperature 
established by a thermocouple in the probehead).  The sample temperature was 
adjusted according to the effects of sample heating by MAS spinning, which 
heats the sample by 1.8 K at 10 kHz spinning.    
 
All of the NMR data was processed using TopSpin version 1.3 (Bruker 
Instruments, Karlsruhe, Germany).  NOESY peak volumes were obtained by 
peak fitting and integration using CARA
13
.  
 
NOESY Cross-Relaxation Rates and Location Probability Determination - The 
NOESY cross-relaxation rates were obtained at a range of mixing times and at 
three temperatures: 298 K, 308 K, 316 K.  The full matrix analysis approach was 
used to calculate cross-relaxation rates of cross-peaks using data obtained from 
the NOESY spectrum
14
.  The experimentally measured NOESY peak volumes, 
represented by the matrix, A, at the mixing time tm, and the cross-relaxation rates, 
R, are linked by the following matrix equation (Equation 13): 
 
     mm RtAtA  exp0  
 
Equation 13 
 
The relaxation rate matrix, R, is calculated by rewriting equation 13: 
 
 
mt
XDX
R
1ln 
  
 
Equation 14 
 
In equation 14, X is the matrix of eigenvectors, and D is the diagonal matrix of 
eigenvalues of the normalised peak volume matrix, a(tm) (where a(tm) = A(tm) 
 [(A(0)
-1
]).  The relaxation rates, contained in R, were taken as indicators of the 
relative location probabilities, and are plotted to give a location profile of the 
agonists, at atomic resolution.  All calculations were carried out using Python 
2.5, specifically with the modules „pylab‟ and „scipy‟15-17.  The calculated cross-
relaxation rates were plotted against carbon number for each measured drug 
resonance. 
 
Part 4. Results and Discussion 
 
NMR Assignments – Figure 4.1 shows the proton spectra of the samples of DPPC 
(A), d62-DPPC/cholesterol (B), d62-DPPC/cholesterol/LY (C) and d62-
DPPC/cholesterol/Q (D) at 300 K and 318 K.  The spectra show the assignments 
of DPPC (peaks a to j), cholesterol (peaks k to p), LY (peaks 1 and 2 in spectrum 
C at 300 K), and Q (peaks 1 and 2 in spectrum D at 318 K). 
 
 
 
Figure 4.1. Proton spectra at temperatures of 300 K and 318 K for samples of 
DPPC (A), d62-DPPC/cholesterol (B), d62-DPPC/cholesterol/LY (C) and d62-
DPPC/cholesterol/Q (D).  Spectrum (A) denotes the DPPC peaks with letters a – 
j, as described in Table 4.1.  Spectra (C) and (D) denote the LY and Q peaks with 
the numbers 1 and 2; spectrum (D) denotes the cholesterol peaks with letters k – 
p, as described in Table 4.4 
 
 
 The assignments for the lipid, cholesterol and drug signals were allocated 
according to studies by Lopez and Lorch, Scheidt et al. and Soubias et al
9, 10, 18
.  
The DPPC proton assignments are shown in Table 4.1, in order of increasing 
chemical shift (ppm). 
 
Carbon number Resonance/ppm 
C16 0.9 
CH2 (n) 
The aliphatic lipid chain atoms 
~ 1.2 
C3 1.6 
C2 2.3 
γ, Gamma 3.3 
β, Beta 3.7 
G3  4.0 
Overlapped G1 and α, alpha resonances 4.35 
G2 5.3 
 
Table 4.1. DPPC Proton Resonances 
 
Figure 4.2 shows an annotated molecule of DPPC, displaying the parts of the 
lipid referred to by carbon number in Table 4.1. 
 
 
 
Figure 4.2. Annotated DPPC molecule indicating the positions of the labelled 
resonances 
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 The serotonin-receptor agonists‟ resonances (Q and LY) were also numbered in 
order of increasing chemical shift (ppm).  These are shown in Tables 4.2 and 4.3. 
 
Carbon number Q resonance/ppm 
Q1 3.45 
Q2 7.17 
Q3 7.33 
Q4 7.47 
Q5 7.60 
Q6 7.75 
Q7 7.97 
 
Table 4.2. Q proton resonances 
 
Figure 4.3 shows the annotated structure of Q, showing the positions of 
resonances 1 and 2. 
 
 
 
Figure 4.3. Annotated quipazine molecule indicating the positions of resonances 
1 and 2 
 
 
 Carbon number LY resonance/ppm 
L1  2.8 
L2 6.7 
L3 7.0 
L4 7.4 
 
Table 4.3. LY proton resonances 
 
Figure 4.4 shows the structure of LY.  The labelled molecules correspond to 
signals 1 and 2 shown in the proton spectrum of d62-DPPC/cholesterol/LY.   
 
 
 
Figure 4.4. Annotated LY molecule indicating the positions of resonances 1 and 
2 
 
The cholesterol proton assignments are shown in Table 4.4, in order of increasing 
chemical shift (ppm). 
 
Carbon number Resonance/ppm 
C18
C 
0.8 
C26/27
C 
0.9 
C9/21/19
C 
1.05 
C14/17/24
C 
1.20 
C7/8/11/15/25
C 
1.50 
C4
C 
2.3 
 
Table 4.4. Cholesterol proton resonances 
 Figure 4.5 shows an annotated molecule of cholesterol, displaying the parts of 
the lipid referred to by carbon number in Table 4.4. 
 
 
 
Figure 4.5. Annotated cholesterol molecule indicating the positions of the 
labelled resonances 
 
The use of a chain-deuterated phospholipid eliminates signals in the aliphatic 
region of the spectrum (0 ppm to 1.6 ppm), thereby ensuring that the previously 
hidden cholesterol aliphatic and methyl signals become visible.  This enables the 
observation of cholesterol/agonist cross-peaks which would otherwise be 
obscured by much more intense phospholipid/agonist cross-peaks.   
 
A typical NOESY spectrum of the sample of d62-DPPC/cholesterol/LY is shown 
in Figure 4.6, showing the cross-peaks arising between the lipid, cholesterol and 
agonist resonances.  The cross-peak intensity gives an indication of the proximity 
of two peaks.  The calculated cross-peak rates were used to generate plots of 
location probability versus lipid number for each drug resonance.   
 
  
 
Fig. 4.6.  MAS-NOESY spectrum of d62-DPPC/cholesterol/LY at a temperature of 
300 K and a mixing time of 200 ms.  The spectrum shows the positions of the 
cholesterol (0 to 2.5 ppm), lipid (3 to 6 ppm) and agonist peaks (2.8 ppm and 6.5 
to 7. 5 ppm) along the diagonal.  The cholesterol/agonist and lipid/agonist cross-
peaks are also indicated 
 
NOESY Location Probabilities for the DPPC/Agonist Samples – NOESY 
experiments were carried out on samples of DPPC/Q and DPPC/LY at a 
temperature of 310 K, at mixing times of 10, 100, 200, and 400 ms.  At this 
temperature both samples are in the fluid lamellar phase, as indicated by the 
results discussed in Chapter 3.  The cross-relaxation rates calculated for these 
samples are displayed in Figure 4.7. 
 
  
 
Fig. 4.7.  Cross-relaxation rates for the samples of DPPC/LY (A) and DPPC/Q 
(B).  The black bars (left axes) represent position 1 of each agonist, while the 
grey bars (right axes) represent position 2, as indicated in figures 3.3 and 3.4 
(Experimental section, Chapter 3).  The cross-relaxation rates are the mean of 
the results from three mixing times.  The error bars represent the standard 
deviation 
 
The results for the sample of DPPC/LY show that there is very little interaction 
between the agonist and the carbon atoms in the headgroup (γ, β and α 
resonances) and chain terminus (C16) regions.  The strongest interactions occur 
between the agonist and the carbon atoms in the interfacial region (C3, C2 and 
G2 resonances).  The interactions between the carbon atoms in the headgroup 
and chain terminus regions and the agonist at position 1 are stronger overall than 
for position 2.  The strongest interaction for position 1 occurs at C3, with weaker 
interactions for C2, G2 and α.  The strongest interaction for position 2 occurs at 
C2, with weaker interactions for C3 and G2.   
 
The results for the sample of DPPC/Q show a distinct difference from those of 
DPPC/LY, with interactions occurring between a greater number of lipid 
resonances.  There is very little interaction between the agonist and the carbon 
atoms in the headgroup (β and γ resonances).  The strongest interactions occur 
between the agonist and the carbon atoms in the chain (C15-4 resonances) and 
interfacial (C3, C2 and G2 resonances) regions, with weaker interactions 
occurring in the chain terminus (C16) region and for the α resonance.  The 
interactions between the lipid and the agonist at position 2 are stronger overall 
 than for position 1, except in the headgroup region (γ and α resonances) and for 
C3.   
 
The results for the sample of DPPC/LY indicate that the agonist is oriented 
perpendicular to the bilayer normal axis, in the interfacial region of the bilayer.  
The interactions between the lipid and the agonist at positions 1 and 2 are similar 
in intensity and occur at the same resonances.  An approximate location and 
orientation of the agonist with respect to the lipid is displayed in Figure 4.8. 
 
 
 
Fig. 4.8. The relative locations and orientations of LY and Q  
 with respect to DPPC at 310 K.  LY is oriented perpendicular to the lipid, and 
located in the interfacial region of the bilayer.  Q is oriented parallel to the lipid, 
and located in the interfacial region and at the start of the headgroup and chain 
regions 
 
The results for the sample of Q indicate that the agonist is located parallel to the 
bilayer normal axis, in the interfacial region of the bilayer.   The differences 
between the interactions at position 1 and position 2 with the lipid indicate that 
the terminal benzene ring (position 2) is positioned towards the chain region of 
the lipid, while the piperazine ring (position 1) is positioned towards the 
headgroup region.   
 The increased amount of interactions between the agonist and the lipid in the 
case of Q may indicate that this molecule experiences greater movement within 
the bilayer than LY, which is concentrated in the interfacial region with very 
little interaction in either the chain or headgroup regions.  In contrast, Q has 
recorded interactions at the extremes of the lipid molecule (the lipid termini (C16 
and γ resonances)). 
 
NOESY Location Probabilities for the d62-DPPC/cholesterol/agonist Samples – 
NOESY experiments were carried out on samples of d62-DPPC/cholesterol/Q and 
d62-DPPC/cholesterol/LY at temperatures of 300 K, at mixing times of 10, 200, 
300 and 400 ms, and 318 K, at mixing times of 20, 400, 500, and 600 ms.  The 
mixing times are increased at higher temperatures to account for an decrease in 
correlation times
4
.  At 300 K the sample of d62-DPPC/cholesterol/Q is in the 
mixed [gel + lo] phase, while the sample of d62-DPPC/cholesterol/LY is in the 
mixed [ld + lo] phase.  At 318 K the sample containing Q is in the fluid lamellar 
phase, although the sample containing LY is still in the mixed [ld + lo] phase.  
The sample of d62-DPPC/cholesterol/LY could not be measured in the fluid 
lamellar phase as the increase in temperature (the pure fluid lamellar phase does 
not start until 327 K) would produce correlation times too short to be practically 
analysed; however the amount of ld phase lipid will be significantly greater at the 
higher temperature.  The phases are identified in Chapter 3.  The cross-relaxation 
rates calculated for these samples are displayed in Figure 4.9. 
 
  
 
Fig. 4.9. Cross-relaxation rates for the samples of d62-DPPC/cholesterol/LY at 
300 K (A) and at 318 K (C), and d62-DPPC/cholesterol/Q at 300 K (B) and at 
318 K (D).  The black bars (left axes) represent position 1 of each agonist, while 
the grey bars (right axes) represent position 2.  The cross-relaxation rates are 
the mean of the results from three mixing times.  The error bars represent the 
standard deviation 
 
The results for d62-DPPC/cholesterol/LY at 300 K show that for position 1, the 
strongest interactions occur at the C18
C
 and C9/19/21
C
 cholesterol resonances, 
with weaker interactions found for the C14/17/24
C
 and C4
C
 resonances.   These 
cholesterol resonances are all located in the main sterol body of the molecule.  
Cholesterol has been found to orient parallel to the bilayer normal axis, with the 
hydroxyl chain terminus located in the interfacial region of the bilayer and the 
terminal aliphatic methyl groups (C26/27
C
) located towards the end of the chain 
region (Figure 4.10)
9
. 
 
  
 
Fig. 4.10. The relative locations and orientations of LY and cholesterol  with 
respect to DPPC at 318 K and 300 K.  The presence of cholesterol in the lo phase 
at 300 K pushes the agonist deeper into the bilayer.  Cholesterol is oriented 
parallel to the bilayer normal axis, with the hydroxyl terminus located in the 
interfacial region and the terminal aliphatic methyl terminus located in the chain 
region 
 
There are significant differences between the lipid and cholesterol interactions 
for position 1 and position 2 .  For position 2, the strongest interactions occur at 
the C9/19/21
C
, C7/8/11/15/25
C
, and G2 resonances, with weaker interactions 
occurring at the C4
C
 positions.  The weakest interactions for positions 1 and 2 
occur in the headgroup region of the lipid, while the weakest interactions for 
position 2 occur at the C18
C
 and C14/17/24
C
 resonances.   
 
These results indicate that the LY molecule is oriented perpendicular to the sterol 
body of the cholesterol molecule, with both located in the interfacial region of 
the bilayer.  At a temperature of 300 K, both parts of the LY  molecule interact 
strongly with the main sterol body of the cholesterol molecule.  At this 
temperature the sample is in the mixed [ld + lo] phase.  The strong interactions of 
 LY with cholesterol suggest that the agonist molecule is present in the 
cholesterol-rich lo domains which proliferate in this mixed phase system. 
 
The profile of cross-relaxation rate interactions changes when the temperature is 
increased to 318 K (and the phase changes to the fluid lamellar phase).  There are 
now significant interactions between LY at position 1 and the lipid which were 
not present at 300 K.  The interactions with the lipid headgroup (α, β and γ 
resonances) and with G2 are strengthened, while the interactions with the main 
sterol body of the cholesterol molecule are weaker.  This pattern of stronger 
interactions with the lipid headgroup and interfacial region is also observed for 
position 2, although the interactions with the cholesterol molecule remain 
relatively strong.  The strengths of the interactions with the lipid molecule have 
increased, which suggests that at lower temperatures the agonist is pushed deeper 
into the bilayer, towards the chain terminus and away from the headgroup, by the 
presence of cholesterol. 
 
The results for d62-DPPC/Chol/Q at 300 K show a markedly different cross-
relaxation rate profile when compared to those for the samples containing LY.  
For position 1, strong interactions occur at all cholesterol and lipid resonances 
apart from the C26/27
C
 and C18
C
 resonances.  For position 2, the strongest 
interactions occur for the main sterol body of the cholesterol molecule (C18
C
, 
C9/19/21
C
, C14/17/24
C
 and C4
C
 resonances), with weaker interactions occurring 
for the C7/8/11/15/25
C
 and G2 resonances.  The weakest interactions occur at the 
lipid headgroup and cholesterol aliphatic chain terminus regions.  These results 
indicate that the Q molecule is in contact with almost all parts of the cholesterol 
and lipid molecules, in contrast to the results for LY at this temperature.  This 
indicates that Q has retained its orientation with respect to the bilayer in the 
presence of cholesterol.  The relative orientations and locations of cholesterol, 
lipid and agonist are shown in Figure 4.11.   
 
  
 
Fig. 4.11. The relative locations and orientations of Q and cholesterol with 
respect to DPPC at 300 K and 318 K.  The presence of cholesterol in the lo phase 
at 300 K pushes the agonist closer towards the surface of the bilayer.   
Cholesterol is oriented parallel to the bilayer normal axis, with the hydroxyl 
terminus located in the interfacial region and the terminal aliphatic methyl 
terminus located in the chain region 
 
At 318 K the sample containing Q is in the fluid lamellar phase, according to the 
results from Chapter 3.  The cross-relaxation rate profile at this temperature is 
similar to that of 300 K, but with markedly reduced interactions between the 
agonist and the lipid headgroup.  The pattern of interactions between the agonist 
and the cholesterol molecule remains similar.  This suggests that the presence of 
the cholesterol-enriched lo phase, which is present at 300 K but not at 318 K, 
may have the effect of pushing the quipazine molecule towards the surface of the 
bilayer, causing increased amounts of agonist/headgroup interaction at the lower 
temperature. 
 
 The addition of cholesterol has a significant effect on the samples of d62-
DPPC/cholesterol/agonist.  In the case of Q, the most significant difference is 
observed at 318 K, with the decreased strength of interactions of the agonist with 
the lipid headgroup (in comparison to the sample of DPPC/Q at 310 K).  
Although at these temperatures both samples are in the fluid lamellar phase, the 
interactions with the headgroup lipids are enhanced by the presence of 
cholesterol, which may indicate that the cholesterol has altered the location of Q 
with respect to the lipid molecule.  It is difficult to make similar comparisons in 
the case of LY, however, because the phase of the sample of DPPC/LY at 310 K 
exists in the fluid lamellar phase, while the sample of d62-DPPC/cholesterol/LY 
exists in the mixed [ld + lo] phase at both temperatures.   
 
The Effect of Agonist Molecules on the Bilayer – The results suggest that Q and 
LY, despite differing only slightly in terms of molecular structure and size, have 
significantly different effects on the bilayer, both in the presence and absence of 
cholesterol.  Q orients parallel to the bilayer normal axis, in the interfacial region, 
while LY adopts an orientation perpendicular to the bilayer in the same region.  
The reason for this orientation is unknown, as it would appear from the linear 
structure of the molecule that it is particularly well-suited to adopting a parallel 
orientation.  It is possible that the perpendicular orientation has a disruptive 
effect on the bilayer; the results from the phase behaviour of the DPPC/LY 
sample, in which the transition temperature is lowered by several degrees in 
comparison with the Q sample, may point to a disruptive influence on the 
bilayer.   
 
The presence of cholesterol, in the form of cholesterol-enriched microdomains, 
appears to have contrasting effects on the relative positions of the agonists.  Q is 
pushed further towards the phospholipid headgroup, as shown by increasing 
interactions with the headgroup resonances coupled with decreasing interactions 
with the cholesterol aliphatic methyl terminus, while conversely LY is pushed 
further towards the centre of the bilayer.  Both agonist molecules are associated 
with lipid microdomains when the sample is in a mixed lo phase. 
 
 
 Part 5. Conclusions 
 
MAS-NOESY experiments were carried out on samples of DPPC containing 
agonist molecules (Q and LY), and on samples of deuterated DPPC containing 
cholesterol and agonist.  Cross-relaxation rate calculations were carried out using 
the full-mixing time approach to produce plots of cross-peak intensity between 
each lipid and/or cholesterol resonance and the agonist.  The results for the 
samples of DPPC/agonist provided orientations and positions of agonist with 
respect to the bilayer; Q was found to orient parallel to the bilayer normal axis, in 
the interfacial region, while LY was found to adopt a perpendicular orientation 
with respect to the bilayer normal, also in the interfacial region.  These results 
correspond to the research carried out by Lopez and Lorch on samples of 
DOPC/agonist
9
. 
 
The results for the samples of deuterated DPPC/cholesterol/agonist showed that 
Q and LY interacted with the cholesterol in slightly different ways.  At 300 K, in 
the mixed [gel + lo] phase, Q interacted strongly with all parts of the cholesterol 
molecule with the exception of C26/27
C
, and also showed significant interactions 
with the phospholipid headgroup.  When the temperature was increased to 318 K, 
and the phase changed from [gel + lo] to fluid lamellar, the pattern of the 
interactions changed; the strong interactions with the phospholipid headgroup 
were greatly decreased, indicating that Q had moved away from the headgroup as 
temperature increased.  The opposite effect is noted for LY; the results showed 
weak agonist/headgroup interactions at 300 K, which then increased in intensity 
as the temperature increased to 318 K.  This indicates that LY is pushed deeper 
into the bilayer, towards the phospholipid C16 chain terminus, when the 
temperature decreases.  The plots of cross-relaxation rates for LY show different 
profiles at the two temperatures, although the sample of d62-
DPPC/cholesterol/LY is ostensibly in the same mixed [ld + lo] phase at these 
temperatures (the results from Chapter 3 indicate that the onset of the fluid 
lamellar phase takes place at 325 K for this sample); this may be due to the fact 
that the proportion of lo phase lipids at the higher temperature may be reduced as 
the sample approaches the phase transition. 
 
 The cholesterol/agonist cross-relaxation rates for both agonist drugs show that  
both agonists partition into lo-phase domains, a hypothesis which is supported by 
the research cited in the introduction.  Eisensamer et al. reported the co-
localisation of the serotonin receptor protein with serotonin receptor agonist 
drugs in LBD fractions.  The results from this research indicate the partitioning 
of two serotonin receptor agonist drugs into cholesterol-rich domains.  The 
advantage of this partitioning activity is the sequestration of a protein with its 
substrate in close proximity, which enhances the activity of the protein. 
 
The results also show that two drugs with only slightly different molecular 
structures, compositions and sizes (Q has a molecular mass of 213, while LY has 
a molecular mass of 349), and with similar linear structures, can adopt 
completely different orientations in the bilayer.  This shows the importance of 
the analysis of drug/membrane interactions, as drugs which are expected to have 
a similar mode of action may have differing levels of interaction with the cell 
membrane.  It would be interesting to expand this research to include further 
examples of serotonin receptor agonist drugs, as explored by Lopez and Lorch
9
.  
It would also be interesting to observe the behaviour of LY in the fluid lamellar 
phase, but practical difficulties prevent this.   
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 Chapter 5: Use of an Enzyme Substrate to Investigate Bilayer Dynamics 
 
Part 1. Introduction 
 
Dipolar Recoupling On-Axis with Scaling and Shape Preservation (DROSS) – 
The DROSS technique was first developed by Gross et al. to obtain order 
parameter measurements in lipid bilayers from 
13
C-
1
H dipolar couplings
1
.  Order 
parameters for lipid samples were previously obtained from 
2
H-NMR 
measurements, but this technique requires the synthesis of expensive deuterated 
lipid compounds.  The development of DROSS enabled the measurement of lipid 
order parameters of from natural abundance 
13
C signals
1
.  A typical DROSS 
projected spectrum is shown in Figure 5.1. 
 
 
 
Figure 5.1. 2D projected DROSS spectrum of a phospholipid compound, 
showing the 
13
C-
1
H dipolar couplings.  The 
13
C spectrum is shown along the F2 
axis (ppm); 
1
H-
1
H couplings are shown along the F1 axis (Hz).  The width of the 
1
H-
1
H coupling can be used to generate order parameters, using Equation 15 
(Experimental section) 
 
DROSS has been used to study lipid bilayers
1
 and phase behaviour in mixed 
phospholipid/cholesterol systems
2
. 
 
 Fluorescence Emission Spectroscopy of Lipid Bilayers – Fluorescence emission 
spectroscopy of lipid bilayers may be carried out using a fluorophore-labelled 
lipid analogue as a probe, with the advantage that these lipid analogues align 
themselves with the bulk of the lipid bilayer at the correct location and 
orientation, and do not cause too much perturbation of the bilayer, although there 
is an unavoidable perturbation due to the bulky size of the pyrene moiety.  
Depending on where the fluorophore is positioned, they may also report on 
different regions of the bilayer
3
.  Examples of widely-used fluorophore labels for 
lipid analogues are the dipyrenylated phospholipids, such as 1,2-bis-(1-
pyrenedecanoyl)-sn-glycero-3-phosphocholine (Figure 5.2). 
 
 
 
Figure 5.2. Chemical structure of 1,2-bis-(1-pyrenedecanoyl)-sn-glycero-3-
phosphocholine (dipyPC) 
 
The pyrene moieties have certain physical properties which make them 
particularly suited to their use as fluorescence probes in lipid bilayers.  They 
have a tendency to form monomers, dimers and excimers inside the bilayer.  The 
formation of excimers depends on the close proximity (< 3.5 Å) of an excited 
monomer to a ground-state monomer.  If the pyrene moieties also adopt the 
correct orientation (face-to-face), then the excimer will form
4
.  The probability of 
excimer formation depends on the lateral pressure in the acyl region of the 
 bilayer, if the concentration of the fluorescence probe is sufficiently low to 
prevent intermolecular correlations.  Therefore the ratio of excimers to 
monomers can be used as a measure of lateral pressure in the bilayer.  A typical 
fluorescence emission spectrum for a dipyrenyl lipid analogue in a DOPC bilayer 
is shown in Figure 5.3. 
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Figure 5.3. Typical fluorescence emission spectrum for a dipyrenyl lipid 
analogue in a DOPC bilayer, excited at 347 nm.  S2, 1 show monomer excitation 
at 377 nm  and 397 nm, respectively; D shows dimer excitation at 415 nm; and E 
shows excimer excitation at 481 nm 
 
Pyrene-containing lipid analogues have previously been used to study lateral 
diffusion of bilayer lipids, curvature stress, and lipid dynamics
3-5
.   
 
Part 2. Aims 
 
The aim of the experiment was to analyse the effect of changes in bilayer 
composition on the physical properties of the bilayer.  The enzyme-catalysed 
conversion of the lipid di-octanoyl-sn-glycerol (DOG) to phosphatidic acid (PA) 
was utilised by measuring the effect of this conversion on the order parameter of 
a DOPC bilayer.  In theory, the conversion of DOG to PA in a DOPC bilayer is 
 expected to increase the order parameter and the lateral tension within the 
bilayer, relative to the values in the presence of DOG, which is due to the 
structural and physical differences between the lipid molecules. 
 
 
 
Figure 5.4. The positions of DOG and PA relative to DOPC in a bilayer.  The 
interactions of DOG with the bilayer change from occurring mainly in the 
interface and tail regions to the head, interface and tail regions with the addition 
of a phosphate headgroup 
 
DOG and PA are expected to interact with the bilayer in different ways, as 
shown in Figure 5.4.  The addition of the phosphate headgroup increases the 
volume of space in the bilayer occupied by the lipid.  PA is a cone-shaped lipid 
(as pictured in Figure 1.7d, Chapter 1), which increases the tension in the bilayer 
relative to the tension experienced in the presence of a cylindrical lipid (DOG).  
The increase in bilayer tension is expected to produce higher order parameters 
and a higher ratio of excimer to monomer formation. 
 
 Part 3. Experimental 
 
Materials – 1,2-Dioctanoyl-sn-glycerol and 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC) and PA were purchased from Avanti Polar Lipids 
(Alabaster, AL).  All other chemicals including adenosine triphosphate (ATP) 
were purchased from Sigma.  DGK and PIPES buffer were synthesised as 
described in Chapter 2.   
 
Sample Preparation – Samples of DOPC/DOG, DOPC/DOG/DGK, and 
DOPC/PA were prepared at concentrations of 20 mol% DOG or PA, with or 
without DGK.  The typical amount of DOPC used in each experiment was 
approximately 80 mg.  The lipids were co-dissolved in chloroform/methanol (1:1 
v/v).  The solvents were evaporated under vacuum, and the resulting lipid cake 
was suspended in 8.4 mL PIPES buffer (pH 6.8), resulting in a lipid 
concentration of approximately 10 mg mL
-1
.  The suspension was extruded to 
produce 0.2 μm multilamellar liposomes.  DGK was added from a stock solution 
to a molar ratio of 1:2000.  100 mM ATP was then added from a stock solution, 
and the liposomes were left to equilibrate before the ATP was removed by 
dialysing against distilled, deionised water containing charcoal.  The distilled, 
deionised water was exchanged for fresh water in 500 mL amounts for four hours 
before leaving overnight.  Samples were also synthesised without the addition of 
ATP in order to provide a comparison of order parameters. 
 
NMR Measurements – All NMR experiments were carried out on a Bruker 
Avance II 500 MHz spectrometer using a 4-mm MAS probe operating at a 
frequency of 500.1025 MHz (
1
H) and 125.7546 (
13
C).  Experiments were carried 
out at 7 kHz sample spinning.   
 
1H experiments were conducted with a typical π/2 pulse length of 7 µs and a 
relaxation delay of 2 s.  
13C experiments were conducted with a typical π/2 pulse 
length of 3.7 µs.  Proton decoupling was achieved using TPPM.  
31
P experiments 
were typically carried out with 32 (spinning) or 1 k (static) scans, with a π/2 
pulse length of 4.59 μs.  Lipid order parameters were determined by measuring 
1
H-
13
C dipolar couplings using two-dimensional recoupling on-axis with scaling 
 and shape preservation (DROSS) experiments
1
.  DROSS measurements were 
typically carried out with 96 increments and 512 scans per increment, with a 
recycle delay of 2 s.  The 
1
H-
13
C dipolar couplings were taken directly from the 
spectrum and converted to segmental order parameters using the method 
described by Warschawski and Devaux
6
. 
 
All of the NMR data were processed using TopSpin version 1.3 (Bruker 
Instruments, Karlsruhe, Germany). 
 
Fluorescence Emission Spectroscopy – All fluorescence emission experiments 
were carried out by Natalia Goehring and Oscar Ces at the Department of 
Chemistry, Imperial College London.  The results are replicated here with 
permission. 
 
Part 4. Results and Discussion 
 
DROSS Results – DROSS experiments were carried out on samples containing: 
DOPC/DOG; DOPC/DOG/DGK; DOPC/DOG/DGK/ATP; and DOPC/PA.  
DOG and PA were present at 20%, and ATP was removed prior to NMR, as 
described in the Experimental section.  Slices through the DROSS spectra 
display the 
13
C-
1
H splittings for each sample (Figure 5.5). 
 
  
 
Figure 5.5.  
13
C-
1
H splittings for each sample at each DOPC resonance: 
DOPC/PA (the top splitting, 1); DOPC/DOG/DGK (second from the top, 2); 
DOPC/DOG (third from the top, 3); and DOPC/DOG/DGK/ATP (the lowest 
splitting, 4) 
 Order parameters were calculated from the measured 
13
C-
1
H splittings using 
Equation 15
1
: 
 
 
20200

 CHCH
W
S  MHz 
 
Equation 15. Equation for the calculation of order parameter using DROSS, 
where SCH is the 
13
C-
1
H order parameter, WCH is the width of the 
13
C-
1
H dipolar 
splitting, and χ is the scaling factor (equal to 0.393).  The WCH term is divided by 
20200 MHz in the case of methylene protons, and 20800 MHz in the case of 
vinylic protons
2
 
 
The order parameters were then plotted against carbon number for DOPC.  The 
numbered parts of the DOPC molecule are shown in Figure 5.6. 
 
 
Figure 5.6.  DOPC displaying the carbon numbers representing parts of the 
molecule.  Numbers 1 – 18 represent the carbon atoms of the alkyl chain; G1 – 3 
represent the glycerol carbon atoms; and α, β and γ represent the headgroup 
molecules 
 
The plot of order parameters per carbon number for the four samples is shown in 
Plot 5.1. 
 
  
 
Plot 5.1. Plot of order parameter for each carbon moiety of DOPC, represented 
by carbon number.  Samples of DOPC/DOG/DGK (dark grey), DOPC/DOG 
(light grey), DOPC/DOG/DGK/ATP (white), and DOPC/PA (black) are shown 
 
The sample of DOPC/DOG/DGK shows the highest order parameters overall, 
with the greatest difference between order parameter values for this sample and 
the other samples occurring at the α, β and C8 carbon atoms.  For the alkyl chain 
carbons, the order parameter values for this sample are equal to or only slightly 
higher than the values for the other samples.  Order parameter values are lower in 
comparison to the other samples at the C2 and C9 positions. 
 
The order parameter values for the sample of DOPC/DOG are expected to 
closely mirror those of the sample of DOPC/DOG/DGK, due to the fact that the 
only difference between the two samples is a relatively low concentration of 
DGK.  However the order parameters only mirror those of DOPG/DOG/DGK in 
the alkyl chain region, where they are equal to or only slightly lower than the 
results for the DGK-containing sample.  The results are significantly lower than 
for the DGK-containing sample for the β, α and C8 positions, and slightly higher 
than for the C2 and C9 positions.  This suggests that the presence of DGK may 
have an ordering effect on the headgroup region of the DOPC bilayer. 
 
The order parameter values for the sample of DOPC/DOG/DGK/ATP closely 
match those of the sample of DOPC/DOG.  The values are equal or slightly 
 lower for DOPC/DOG/DGK/ATP than for DOPC/DOG in the alkyl chain region, 
suggesting that the order in this region is similar for both samples.  The values 
are also similar in the β, C2 and C8 positions, but vary more in the α and C9 
positions.  The order parameter value for the α-carbon is almost as high as for the 
sample of DOPC/DOG/DGK.  This observation, coupled with the relatively high 
C2 value, may mean that there is a slight ordering effect in the interfacial region 
of the bilayer. 
 
The sample of DOPC/DOG/DGK/ATP contains PA catalysed from DOG by 
DGK in the presence of ATP, and so would be expected to closely match the 
order parameter values found for the sample of DOPC/PA, as the only difference 
between the two samples is the presence of DGK; this has already been shown to 
have a small effect on order parameter, particularly in the headgroup region, 
from comparison of the results for the samples of DOPC/DOG/DGK and 
DOPC/DOG.  The effect from the presence of ATP can be ignored as ATP is 
removed by dialysis prior to the NMR experiment.  However the order parameter 
profile for the sample of DOPC/PA shows significantly lower order parameter 
values overall compared to the three samples previously analysed.  For the C17, 
C11 and β carbon atoms, the splittings are no longer visible for measurement.  
These results show that there is a significant difference between the behaviour of 
DOPC bilayers doped with PA and those in which PA is synthesised from the 
enzyme-catalysed turn-over of DOG. 
 
31
P-NMR Results – 31P-NMR experiments were carried out on samples 
containing: DOPC/DOG/DGK; DOPC/PA; and DOPC/DOG/DGK/ATP.  DOG 
and PA were present at 20%, and ATP was removed prior to NMR, as described 
in the experimental section.  The 
31
P spectra, obtained at a spinning speed of 5 
kHz, are shown in Figure 5.7. 
 
  
 
Figure 5.7.  
31
P-NMR spectra (5 kHz spinning speed) of samples of 
DOPC/DOG/DGK, DOPC/PA, and DOPC/DOG/DGK/ATP 
 
The 
31
P spectrum of DOPC/DOG/DGK displays a single peak, assigned to the 
DOPC phosphate headgroup.  The spectrum of DOPC/PA shows two peaks; one 
corresponding to the DOPC phosphate headgroup, and the other to the PA 
phosphate headgroup.  The spectrum of DOPC/DOG/DGK/ATP also shows two 
peaks; one corresponding to the DOPC phosphate headgroup, and the other to the 
phosphate headgroup from the enzyme-catalysed PA.  The intensity of this peak 
is roughly equal to 20% of the intensity of the DOPC phosphate headgroup peak, 
which suggests that all of the DOG has been converted to PA by the action of the 
enzyme.  The peaks corresponding to the PA phosphate headgroup from the 
sample of DOPC/PA and from the sample of DOPC/DOG/DGK/ATP have 
different chemical shift values, which indicates that the two types of PA are in 
different chemical environments. 
 
Fluorescence Results – Fluorescence emission spectra were obtained for samples 
of: DOPC/DOG + DGK; DOPC/PA + DGK; DOPC/DOG/ATP + DGK; and 
DOPC/PA/ATP + DGK.  Ratios of excimer formation (E) over monomer 
formation (S
2
) were obtained from the emission spectrum for each sample.  The 
E/S
2
 ratio gives an indication of the lateral stress in the bilayer in the acyl chain 
region.  The E/S
2
 ratio for each sample is shown in Figure 5.8. 
  
Figure 5.8. Plot of E/S
2
 ratio for each sample: DOPC/DOG+ DGK; DOPC/PA 
+ DGK; DOPC/DOG/ATP + DGK; and DOPC/PA/ATP + DGK, where the 
black bars represent the DGK-containing samples and the grey bars represent 
the samples containing no DGK 
 
The highest E/S
2
 ratios are found for both DOPC/DOG + DGK samples, which 
matches the observation that the highest order parameters were found for these 
samples.  The E/S
2
 ratios for these samples are identical.  The next highest E/S
2
 
ratio is found for the sample of DOPC/DOG/ATP/DGK, with a slight decrease 
observed for the sample of DOPC/DOG/ATP.  The E/S
2
 ratios for the samples 
containing DOG, and notably for the sample containing PA catalysed from DOG 
by DGK, are higher overall than the E/S
2
 ratios for the samples containing PA. 
 
These results suggest that lateral bilayer pressure is highest for the DOG samples 
containing DGK, which correlates with the relatively high acyl chain region 
order parameters observed for these samples.  Lateral bilayer pressure is slightly 
higher for the sample of DOPC/DOG/ATP plus DGK than for the non-DGK 
sample, but there is no difference for the DGK and non-DGK samples of 
DOPC/DOG.  The bilayer pressure is significantly decreased for both the 
DOPC/PA and DOPC/PA/ATP samples, with and without DGK, which is also 
observed in the order parameter results for these samples. 
 
Differences Between Doped and Enzyme-Catalysed PA in DOPC Bilayers – The 
results from the DROSS and fluorescence emission spectroscopy experiments 
display an interesting difference between the behaviour of a DOPC bilayer when 
 PA is co-dissolved with DOPC during liposome formation, and when PA is 
synthesised from the catalysis of DOG by DGK.  The results show that the order 
parameters and lateral bilayer pressures of the samples containing co-dissolved 
PA are significantly higher than those of the samples containing turned-over PA, 
and that the presence of turned-over PA does not significantly change the 
behaviour or physical properties of the lipid bilayer. 
 
The relatively low bilayer tension associated with the presence of co-dissolved 
PA is due to the phosphate headgroup allowing the molecules to intercalate 
efficiently with neighbouring phospholipids.  The absence of the phosphate 
headgroup (as in DOG) prevents efficient intercalation with DOPC, thereby 
increasing the order parameter and lateral pressure.  It was expected that the 
enzyme-catalysed synthesis of PA from DOG would reduce the order parameter 
and lateral pressure of the sample to the same degree as for co-dissolved PA, but 
this was not observed to happen; in fact, there was a very slight decrease in these 
parameters.  The removal of ATP and ADP prior to making the measurements 
ensures that the samples containing co-dissolved PA and turned-over PA were 
identical.  
31
P-NMR results also showed that all of the DOG had been converted 
to PA; hence, there was no remaining DOG to affect the order parameter and 
lateral pressure measurements.  Therefore the differences between the sets of 
results must be due to differences between the behaviour of co-dissolved and 
turned-over PA. 
 
It is assumed that co-dissolving PA with DOPC results in an even distribution of 
PA throughout the main DOPC bulk.  The difference between order parameter 
and lateral pressure for the two types of PA may be due to an uneven distribution 
of turned-over PA compared to co-dissolved PA.  Each trimer of DGK is 
surrounded by an annulus of 25 to 50 lipids.  The concentration of the protein in 
these samples is 1:2000 for DOPC, and 1:400 for PA.  Two rings of lipid 
molecules around the protein could account for approximately 300 PA 
molecules.  The sequestration of PA in the vicinity of DGK could account for the 
relatively small decrease in order parameter and lateral pressure in the bilayer, as 
the enzyme-catalysed PA does not intercalate with DOPC.  PA molecules, which 
contain a negatively-charged phosphate headgroup, may be attracted to positive 
 amino acid residues - this effect would also result in sequestration of PA away 
from the DOPC bulk.   However, analysis of the topology of DGK suggests that 
there are few charged amino acid residues present in the lipid bilayer
7
.   
 
Part 5. Conclusion 
 
DROSS-NMR and fluorescence emission spectroscopy experiments were carried 
out on DOPC bilayers containing DOG, PA, and DGK in order to investigate the 
difference in lipid behaviour and physical properties between co-dissolved PA, 
which was mixed with DOPC before liposome formation, and enzyme-catalysed 
PA, which was synthesised from the catalysis of DOG in the presence of ATP.  
The experiments measured order parameters and bilayer lateral pressures, 
respectively.  DOPC bilayers containing DOG and turned-over PA were found to 
have higher order parameters and lateral pressures overall when compared to 
those containing co-dissolved PA.  There was only a small difference between 
the order parameters and lateral pressures of the DOPC/DOG bilayers and the 
DOPC/turned-over PA bilayers. 
 
The explanation for the observed differences may lie in the different distributions 
of co-dissolved PA and turned-over PA in a DOPC bilayer.  Co-dissolved PA is 
expected to have an even distribution throughout the bilayer, and is expected to 
intercalate efficiently with DOPC molecules, thereby producing low bilayer 
tensions.  The higher bilayer tensions observed for turned-over PA may result 
from sequestration of PA in the lipid annulus of DGK.  This experiment has 
shown that the behaviour and physical properties of a lipid component in a model 
membrane formed by co-dissolving two or more lipids may differ considerably 
from the behaviour of the same lipid when produced in vitro through enzyme 
catalysis.   
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 Conclusion 
 
The aim of the research was to assess the use of enzymes, isomerisable lipid 
analogues, and small molecules to modulate the structure and dynamics of lipid 
bilayers.  The effects of the bilayer modulation were measured using various 
NMR spectroscopic methods, DSC, fluorescence emission spectroscopy, and 
enzyme assay experiments.  Overall the research showed that the effect of small 
molecules and enzyme-catalysed substrates on the structure and properties of the 
bilayer may be unexpected. 
 
The analysis of phase behaviour of d62-DPPC bilayers containing cholesterol and 
serotonin-receptor agonist drugs showed that the presence of a relatively small 
molecule in a bilayer may cause a significant change to the phase behaviour by 
lowering phase transition temperatures, elongating phase transition boundaries, 
and removing sub-fluid lamellar phases such as the ripple phase.  NOESY cross-
relaxation rates also showed that small molecules may adopt an unexpected 
orientation in the bilayer; LY was found to lie perpendicular to the bilayer 
normal, although it has a relatively linear structure, while Q was found to adopt 
an orientation parallel to the bilayer.  The NOESY results also showed that 
drug/cholesterol interactions cause the drug to change position as the temperature 
in the bilayer increases.  LY was found to move towards the headgroup region of 
the bilayer as the temperature increased, while Q moved towards the centre of the 
bilayer.  These results show that small molecules in vivo such as these serotonin-
receptor agonists may adopt unpredictable positions in the membrane and may 
affect the membrane‟s physical properties. 
 
The analysis of bilayer tension and order parameter for samples containing 
enzyme-catalysed PA and co-dissolved PA also produced unexpected results.  
Bilayer tension was found to be much higher for enzyme-catalysed PA than for 
co-dissolved PA, which may be due to sequestration of the PA in the protein‟s 
lipid annulus. 
 
A photoisomerisable azobenzene lipid analogue was synthesised for inclusion 
into DOPC liposomes containing DGK, but the enzyme activity assay for each 
 photochemical state was not sufficiently different to enable the effect of 
photoswitching on enzyme activity to be confidently assessed.  However the 
azobenzene lipid analogue was characterised and was shown to produce a 
relatively small amount of aggregation in the liposome. 
